The present disclosure generally relates to medical devices for the treatment of musculoskeletal disorders, and more particularly to a surgical system that includes an expandable spinal implant, systems for implanting an expandable spinal implant, and a method for treating a spine.
Spinal disorders such as degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, scoliosis and other curvature abnormalities, kyphosis, tumor, and fracture may result from factors including trauma, disease and degenerative conditions caused by injury and aging. Spinal disorders typically result in symptoms including pain, nerve damage, and partial or complete loss of mobility.
Non-surgical treatments, such as medication, rehabilitation and exercise can be effective, however, may fail to relieve the symptoms associated with these disorders. Surgical treatment of these spinal disorders includes fusion, fixation, correction, discectomy, laminectomy and implantable prosthetics. As part of these surgical treatments, spinal constructs, such as, for example, bone fasteners, spinal rods and interbody devices can be used to provide stability to a treated region. For example, during surgical treatment, interbody devices may be introduced to a space between adjacent vertebral bodies (the interbody space) to properly space the vertebral bodies and provide a receptacle for bone growth promoting materials.
More recently, interbody devices have been introduced that provide additional capability beyond static spacing of the vertebral bodies. For example, some devices have expansion capability such that the implant may be introduced to the interbody space in a collapsed state and then expanded to produce additional spacing and, in some cases, introduce or restore curvature to the spine by expanding selectively on only one end or portion of the implant. However, many existing expandable interbody designs have limited ranges of expansion.
An additional problem exists related to subsidence of spinal surfaces due to existing interbody devices having inadequately-sized load-bearing surfaces. In the case of expandable devices, the loads on the load-bearing surfaces, including loads generated during expansion of the implant, are often significant. An expandable implant with relatively large surface areas is needed to bear the loads, including the loads generated during implant expansion, in an attempt to avoid a need for follow-on surgery due to subsidence of spinal surfaces.
A further problem is instability of existing expandable interbody devices as they are expanded. Often, the load-bearing surfaces move relative to one another, as well as relative to an inserter, as the interbody device is expanded such that there is a risk of undesired shifts in the positioning of the interbody device within the intervertebral space.
The present invention seeks to address these and other shortcomings in the existing art.
In one aspect, the present disclosure provides an expandable spinal implant deployable between a contracted position and an expanded position in a disc space between two vertebral bodies, the expandable spinal implant comprising a first endplate, the first endplate including an outer surface and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end; a second endplate, the second endplate including an outer surface and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end, wherein the second endplate first end is pivotably engaged with the first endplate first end; an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism including a wedge disposed between the first endplate and second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a wedge aperture between the wedge second end and wedge first end; a rod assembly, the rod assembly having a first end and a second end defining a longitudinal axis, wherein at least a portion of the rod assembly is disposed within the wedge aperture and operably engaged with the wedge to translate the wedge along the longitudinal axis of the rod; and wherein the wedge is operably engaged with at least one of the first endplate or second endplate and configured to expand the implant when the wedge is translated along the rod assembly in a first direction, and contract the implant when the wedge is translated along the rod assembly in a second direction.
In some embodiments, the rod assembly comprises a threaded outer surface, and the wedge aperture comprises a threaded inner surface operably engaged with the threaded outer surface of the rod.
In some embodiments, the translation of the wedge along the longitudinal axis of the rod in a first direction is towards the first and second endplate first ends. In some embodiments, translation of the wedge along the longitudinal axis of the rod in the first direction is towards the first and second endplate second ends.
In some embodiments, at least one of the first endplate or the second endplate further comprises at least one protrusion from its inner surface configured to engage a surface of the wedge. In some embodiments, at least one of the wedge first lateral surface and the wedge second lateral surface comprises a lateral post extending therefrom.
In some embodiments, at least one of the first endplate or second endplate further comprises at least one protrusion from its inner surface, wherein the at least one protrusion defines at least one lateral channel configured to receive the lateral post such that when the wedge is translated in the first direction, the lateral post of the wedge is moved in the first direction in the lateral channel to expand the implant and that when the wedge is translated in the second direction, the lateral post of the wedge is moved in the second direction in the lateral channel to contract the implant.
In some embodiments, the expandable spinal implant further comprises at least one vertebral endplate engagement component operably engaged to at least one of the first endplate or the second endplate and configured to engage with the wedge such that it protrudes from the outer surface of the first or second endplate when the wedge is translated in the first direction. In some embodiments, the vertebral endplate engagement component is configured to engage with the wedge such that it retracts from the outer surface of the first or second endplate when the wedge is translated in the second direction.
In some embodiments, the expandable spinal implant is capable of expanding up to 30 degrees, 35 degrees, 40 degrees, 45 degrees, 50 degrees, or 60 degrees or anywhere in between these amounts from 0 to 60 degrees.
In some embodiments, the expansion mechanism is secured to the second endplate. In some embodiments, the first end of the second endplate comprises a first aperture and the second end of the second endplate comprises a second aperture, and wherein the first end of the rod assembly is disposed within the first aperture and the second end of the rod assembly is disposed within the second aperture. In some embodiments, the rod assembly comprises a rod having a first and second end and a securing pin comprising a first and second end, the first end of the rod engaged with the second end of the securing pin, wherein the securing pin is disposed through the first aperture and the second end of the rod is disposed within the second aperture.
In some embodiments, the first endplate first end further comprises at least one protrusion comprising a lumen therethrough extending laterally along the first endplate first end; the second endplate first end further comprises at least one protrusion comprising a lumen therethrough extending laterally along the second endplate first end; and the lumen through the at least one protrusion on the first endplate first end is co-axially aligned with the lumen through the at least one protrusion on the second endplate first end, and a rod is disposed through the lumens to pivotably engage first endplate first end with the second endplate first end.
In some embodiments, at least one of the first or second endplate comprises an aperture disposed therethrough from the outer surface to the inner surface, the aperture configured to receive an external screw for securing the first or second endplate to a vertebral body. In some embodiments, at least one of the first or second endplate comprises a tab extending from the first or second end, wherein the tab comprises an aperture therethrough configured to receive an external screw for securing first or second endplate to a vertebral body.
In some embodiments, at least one of the outer surfaces of the first or second endplates comprise anti-migration and/or anti-expulsion features. In some embodiments, at least one of the first or second endplates comprise apertures between the inner and outer surfaces thereof to allow bone growth material to be loaded into the implant. In some embodiments, at least one of the first or second endplates is porous.
In another aspect, the present disclosure provides an expandable spinal implant system comprising an insertion instrument comprising a drive cannula and a drive shaft removably and rotatably disposed within the drive cannula, and further comprising an attachment cannula and an attachment shaft removably and rotatably disposed within the attachment cannula; and an expandable spinal implant deployable between a contracted position and an expanded position in a disc space between two vertebral bodies, the expandable spinal implant comprising a first endplate, the first endplate including an outer surface and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end; a second endplate, the second endplate including an outer surface and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end, wherein the second endplate first end is pivotably engaged with the first endplate first end; an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism including a wedge disposed between the first endplate and second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a wedge aperture between the wedge second end and wedge first end; a rod assembly, the rod assembly having a first end and a second end defining a longitudinal axis, wherein at least a portion of the rod assembly is disposed within the wedge aperture and operably engaged with the wedge to translate the wedge along the longitudinal axis of the rod; and wherein the wedge is operably engaged with at least one of the first endplate or second endplate and configured to expand the implant when the wedge is translated along the rod assembly in a first direction, and contract the implant when the wedge is translated along the rod assembly in a second direction.
In another aspect, the present disclosure provides a method of deploying an expandable spinal implant in a disc space between two vertebral bodies, the method comprising utilizing an expandable spinal implant deployable between a contracted position and an expanded position in a disc space between upper and lower vertebral bodies, the expandable spinal implant comprising a first endplate, the first endplate including an outer surface and an inner surface, a first endplate first end, a first endplate second end, a first endplate first lateral surface extending between the first endplate first end and the first endplate second end, an opposing first endplate second lateral surface extending between the first endplate first end and the first endplate second end; a second endplate, the second endplate including an outer surface and an inner surface, a second endplate first end, a second endplate second end, a second endplate first lateral surface extending between the second endplate first end and the second endplate second end, and an opposing second endplate second lateral surface extending between the second endplate first end and the second endplate second end, wherein the second endplate first end is pivotably engaged with the first endplate first end; an expansion mechanism disposed between the first endplate and the second endplate, the expansion mechanism including a wedge disposed between the first endplate and second endplate, the wedge including an upper surface, a lower surface, a wedge first end, a wedge second end, a wedge first lateral surface extending between the wedge first end and the wedge second end, and an opposing wedge second lateral surface extending between the wedge first end and the wedge second end, wherein the wedge comprises a wedge aperture between the wedge second end and wedge first end; a rod assembly, the rod assembly having a first end and a second end defining a longitudinal axis, wherein at least a portion of the rod assembly is disposed within the wedge aperture and operably engaged with the wedge to translate the wedge along the longitudinal axis of the rod; and wherein the wedge is operably engaged with at least one of the first endplate or second endplate and configured to expand the implant when the wedge is translated along the rod assembly in a first direction, and contract the implant when the wedge is translated along the rod assembly in a second direction; inserting the implant in the collapsed position into the disc space between the upper and lower vertebral bodies; and expanding the first and second endplates.
In other aspects of the present disclosure, various other implants, systems and methods are disclosed.
The present disclosure is further informed by the specific description accompanied by the following drawings, in which:
Common numbering schemes in
The exemplary embodiments of the surgical system and related methods of use disclosed are discussed in terms of medical devices for the treatment of musculoskeletal disorders and more particularly, in terms of an expandable surgical implant system that may include an expandable spinal implant, an insertion instrument, specialized instruments such as, for example, an expandable retractor and a spinal surgical table that rotates and bends the patient in various directions, and/or a method or methods for treating a spine.
In some embodiments, the present system includes an expandable spinal implant suitable for insertion from an oblique, postero-lateral procedures and/or transforaminal lumbar interbody fusions (sometimes referred to as TLIF procedures), direct posterior (sometimes referred to as PLIF procedures), direct lateral (sometimes referred to as DLIF procedures), anterior lumbar interbody fusions (sometimes referred to as ALIF procedures), or variations of these procedures, in which the present implant is inserted into an intervertebral space and then expanded in order to impart and/or augment a lordotic and/or kyphotic curve of the spine.
In some embodiments, the spinal implant system may also be employed to restore and/or impart sagittal balance to a patient by increasing and/or restoring an appropriate lordotic and/or kyphotic angle between vertebral bodies at a selected level where the spinal implant is implanted and expanded. In the various embodiments described, the spinal implant system may be useful in a variety of complex spinal procedures for treating spinal conditions beyond one-level fusions. Furthermore, the spinal implant system described in the enclosed embodiments may also be used as a fusion device with an expandable height for tailoring the implant to a particular interbody disc space to restore the spacing between adjacent vertebral bodies and facilitate spinal fusion between the adjacent vertebral bodies.
In some embodiments, and as mentioned above, the present disclosure may be employed to treat spinal disorders such as, for example, degenerative disc disease, disc herniation, osteoporosis, spondylolisthesis, stenosis, scoliosis and other curvature abnormalities, kyphosis, tumor and fractures. In some embodiments, the present disclosure may be employed with other osteal and bone related applications, including those associated with diagnostics and therapeutics. In some embodiments, the disclosed spinal implant system may be alternatively employed in a surgical treatment with a patient in a prone or supine position, and/or employ various surgical approaches to the spine, including anterior, posterior, posterior mid-line, direct lateral, postero-lateral oblique, and/or antero lateral oblique approaches, and in other body regions. The present disclosure may also be alternatively employed with procedures for treating the lumbar, cervical, thoracic, sacral and pelvic regions of a spinal column. The spinal implant system of the present disclosure may also be used on animals, bone models and other non-living substrates, such as, for example, in training, testing and demonstration.
The present disclosure may be understood more readily by reference to the following detailed description of the embodiments taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this application is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting. In some embodiments, as used in the specification and including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment. It is also understood that all spatial references, such as, for example, horizontal, vertical, top, upper, lower, bottom, left and right, are for illustrative purposes only and can be varied within the scope of the disclosure. For example, the references “upper” and “lower” are relative and used only in the context to the other, and are not necessarily “superior” and “inferior”. Generally, similar spatial references of different aspects or components, e.g., a “first end” of an end plate and a “first end” of a wedge, indicate similar spatial orientation and/or positioning, i.e., that each “first end” is situated on or directed towards the same end of the device. Further, the use of various spatial terminology herein should not be interpreted to limit the various insertion techniques or orientations of the implant relative to the positions in the spine.
As used in the specification and including the appended claims, “treating” or “treatment” of a disease or condition refers to performing a procedure that may include administering one or more drugs, biologics, bone grafts (including allograft, autograft, xenograft, for example) or bone-growth promoting materials to a patient (human, normal or otherwise or other mammal), employing implantable devices, and/or employing instruments that treat the disease, such as, for example, micro-discectomy instruments used to remove portions bulging or herniated discs and/or bone spurs, in an effort to alleviate signs or symptoms of the disease or condition. Alleviation can occur prior to signs or symptoms of the disease or condition appearing, as well as after their appearance. Thus, treating or treatment includes preventing or prevention of disease or undesirable condition (e.g., preventing the disease from occurring in a patient, who may be predisposed to the disease but has not yet been diagnosed as having it). In addition, treating or treatment does not require complete alleviation of signs or symptoms, does not require a cure, and specifically includes procedures that have only a marginal effect on the patient. Treatment can include inhibiting the disease, e.g., arresting its development, or relieving the disease, e.g., causing regression of the disease. For example, treatment can include reducing acute or chronic inflammation; alleviating pain and mitigating and inducing re-growth of new ligament, bone and other tissues; as an adjunct in surgery; and/or any repair procedure. Also, as used in the specification and including the appended claims, the term “tissue” includes soft tissue, ligaments, tendons, cartilage and/or bone unless specifically referred to otherwise. The term “bone growth promoting material” as used herein may include, but is not limited to: bone graft (autograft, allograft, xenograft) in a variety of forms and compositions (including but not limited to morselized bone graft); osteoinductive material such as bone morphogenetic proteins (BMP) (including but not limited to INFUSE® available from Medtronic) and alternative small molecule osteoinductive substances; osteoconductive materials such as demineralized bone matrix (DBM) in a variety of forms and compositions (putty, chips, bagged (including but not limited to the GRAFTON® family of products available from Medtronic)); collagen sponge; bone putty; ceramic-based void fillers; ceramic powders; and/or other substances suitable for inducing, conducting or facilitating bone growth and/or bony fusion of existing bony structures. Such bone growth promoting materials may be provided in a variety of solids, putties, liquids, colloids, solutions, or other preparations suitable for being packed or placed into or around the various implant 10, 20, 30 embodiments described herein.
The following discussion includes a description of a surgical system including one or more spinal implants, related components and methods of employing the surgical system in accordance with the principles of the present disclosure. Various alternate embodiments are disclosed and individual components of each embodiment may be used with other embodiments. Reference is made in detail to the exemplary embodiments of the present disclosure, which are illustrated in the accompanying figures. Turning to
The components of the expandable spinal implant systems described herein can be fabricated from biologically acceptable materials suitable for medical applications, including metals, synthetic polymers, ceramics and bone material and/or their composites. For example, the components of expandable spinal implant system, individually or collectively, can be fabricated from materials such as stainless steel alloys, commercially pure titanium, titanium alloys, Grade 5 titanium, super-elastic titanium alloys, cobalt-chrome alloys, stainless steel alloys, superelastic metallic alloys (e.g., Nitinol, super elasto-plastic metals, such as GUM METAL®), ceramics and composites thereof such as calcium phosphate (e.g., SKELITE™), thermoplastics such as polyaryletherketone (PAEK) including polyetheretherketone (PEEK), polyetherketoneketone (PEKK) and polyetherketone (PEK), carbon-PEEK composites, PEEK-BaSO4 polymeric rubbers, polyethylene terephthalate (PET), fabric, silicone, polyurethane, silicone-polyurethane copolymers, polymeric rubbers, polyolefin rubbers, hydrogels, semi-rigid and rigid materials, elastomers, rubbers, thermoplastic elastomers, thermoset elastomers, elastomeric composites, rigid polymers including polyphenylene, polyamide, polyimide, polyetherimide, polyethylene, epoxy, bone material including autograft, allograft, xenograft or transgenic cortical and/or corticocancellous bone, and tissue growth or differentiation factors, partially resorbable materials, such as, for example, composites of metals and calcium-based ceramics, composites of PEEK and calcium based ceramics, composites of PEEK with resorbable polymers, totally resorbable materials, such as, for example, calcium based ceramics such as calcium phosphate, tri-calcium phosphate (TCP), hydroxyapatite (HA)-TCP, calcium sulfate, or other resorbable polymers such as polyaetide, polyglycolide, polytyrosine carbonate, polycaprolactone and their combinations.
Various components of spinal implant system may be formed or constructed of material composites, including but not limited to the above-described materials, to achieve various desired characteristics such as strength, rigidity, elasticity, compliance, biomechanical performance, durability and radiolucency or imaging preference. The components of expandable spinal implant system, individually or collectively, may also be fabricated from a heterogeneous material such as a combination of two or more of the above-described materials. The components of the expandable spinal implant systems may be monolithically formed, integrally connected or include fastening elements and/or instruments, as described herein. For example, in some embodiments the expandable spinal implant systems may comprise expandable spinal implants 10, 20, 30 comprising PEEK and/or titanium structures with radiolucent markers (such as tantalum pins and/or spikes) selectively placed in the implant to provide a medical practitioner with placement and/or sizing information when the expandable spinal implant 10, 20, 30 is placed in the spine. The components of the expandable spinal implant system may be formed using a variety of subtractive and additive manufacturing techniques, including, but not limited to machining, milling, extruding, molding, 3D-printing, sintering, coating, vapor deposition, and laser/beam melting. Furthermore, various components of the expandable spinal implant system may be coated or treated with a variety of additives or coatings to improve biocompatibility, bone growth promotion or other features. For example, the endplates 110, 120, 210, 220, 310, 320 may be selectively coated with bone growth promoting or bone ongrowth promoting surface treatments that may include, but are not limited to: titanium coatings (solid, porous or textured), hydroxyapatite coatings, or titanium plates (solid, porous or textured).
The expandable spinal implant system may be employed, for example, with a minimally invasive procedure, including percutaneous techniques, mini-open and open surgical techniques to deliver and introduce instrumentation and/or one or more spinal implants at a surgical site within a body of a patient, for example, a section of a spine. In some embodiments, the expandable spinal implant system may be employed with surgical procedures, as described herein, and/or, for example, corpectomy, discectomy, fusion and/or fixation treatments that employ spinal implants to restore the mechanical support function of vertebrae. In some embodiments, the expandable spinal implant system may be employed with surgical approaches, including but not limited to: anterior lumbar interbody fusions (ALIF), posterior lumbar interbody fusion (PLIF), oblique lumbar interbody fusion, transforaminal lumbar interbody fusion (TLIF), various types of anterior fusion procedures, and any fusion procedure in any portion of the spinal column (sacral, lumbar, thoracic, and cervical, for example).
Generally in
As shown in
Referring generally to
As described herein, the implant 10 may include an expansion mechanism for expanding endplates 110, 120 to increase the lordotic angle R of implant 10. In some embodiments, the expansion mechanism of implant 10 includes a rod assembly 140 having a longitudinal axis E3-E3 comprising a rod 142, a securing pin 143 and wedge 150 mounted within the implant between first endplate 110 and second endplate 120. Wedge 150 may comprise a first end 152, a second end 154, an upper surface 158, a lower surface 156, and opposing lateral surfaces 155 extending between the first and second ends. Wedge 150 may further comprise an aperture 151 between the first and second ends. Rod assembly 140 may comprise rod 142 disposed within aperture 151. In some embodiments, rod 142 comprises a threaded outer surface 141 configured to be engaged with a complimentary inner threaded surface of aperture 151 of wedge 150 such that the wedge 150 travels forward and backwards along rod 142 between first and second ends of implant 10 when rod 142 is rotated relative to wedge 150. In some embodiments, rod 142 and securing pin 143 may be integrally formed, and in such embodiments, it will be understood that integral rod assembly 140 may be interchanged with rod 142 in the discussions below.
The expansion mechanism of implant 10 may be operably engaged with first or second endplates 110, 120. In some embodiments, the expansion mechanism of implant 10 is secured to second endplate 120. Hinge protrusion 127 of second endplate 120 may comprise a first end aperture 127a through the walls of hinge protrusion 127 and generally perpendicular to lumen 127b therethrough. Second end 124 of second endplate 120 may further comprise an aperture 124a therethrough. In some embodiments, apertures 127a and 124a are generally co-axial. One or both ends of rod assembly 140 may be secured within one or both of aperture 124a of second end 124 and first aperture 127a of hinge protrusion 127 along first end 122 to operably engage the expansion mechanism of implant 10 with second endplate 120. In the embodiment shown, second end of rod 142 is secured within aperture 124a, and a cylindrical securing pin 143 disposed through aperture 127a coaxially engages an end of rod 142 to further secure the expansion mechanism within implant 10. Pin 130 disposed within the lumen of hinge protrusions 117, 127 may include a cut out portion 131 to allow rod 142 and/or cylindrical securing pin 143 to be disposed through aperture 127a. In some embodiments, rod assembly 140 is disposed such that longitudinal axis E1-E1 is substantially parallel to mid-longitudinal axis L1-L1 of implant 10 (i.e., perpendicular to hinge axis H1-H1). In some embodiments, apertures 124a and 127a may be aligned such that rod assembly 140 is disposed such that longitudinal axis E1-E1 is at an oblique angle to the mid-longitudinal axis L1-L1 of implant 10 (e.g., between zero and 90 degrees).
Rod 142 may be rotatable within apertures 124a, 127a relative to implant 10. Inner surface 116 of first endplate 110 may comprise guidewalls 116a extending away from the inner surface 116 of first endplate 110. In some embodiments, guidewalls 116a extend perpendicularly away from inner surface 116 of first endplate 110. In some embodiments, guidewalls 116a are oriented substantially parallel to the longitudinal axis L of rod 142 and are disposed a width W apart from one another. In some embodiments, the width W is substantially similar to the width of wedge 150, with wedge 150 being disposed between guidewalls 116a. Lateral sides 155 of wedge 150 engage with guidewalls 116a such that rotation of wedge 150 relative to implant 10 is prevented. In this way, the interaction between threaded surfaces 141, 151 cause wedge 150 to translate along longitudinal axis L of rod 142 when rod 142 is rotated.
Wedge 150 may include an upper surface 158 configured to engage with inner surface 116 of first endplate 110 and lordotically expand first endplate 110 away from second endplate 120 when wedge 150 is moved towards first end 12 of implant 10. For example, upper surface 158 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inside of first endplate 110 so as to gradually move first endplate 140 away from second endplate 150 as wedge 150 is advanced towards first end 12 along rod 142. In the embodiment depicted, inner surface 116 of first endplate 110 may further comprise ramps 116b to engage upper surface 158 of wedge 150. In some embodiments, the expansion mechanism may be configured such that lower surface 156 of wedge 150 engages inner surface 126 of second endplate 120 alternatively to, or in addition to, upper surface 158 engaging inner surface 116 of first endplate 110. In some embodiment, the expansion mechanism may be configured to lordotically expand implant 10 when wedge 150 is moved towards the second end 14 of implant 10.
In some embodiments, the ramp mechanism 158/116b may cooperate with one or more paired lateral posts 155a and channel 116c system in order to optimize the opening and/or expansion of implant 10. Guidewalls 116a may comprise lateral channels 116c. Channels 116c may be angled or partially angled to provide a mechanism for assisting in the expansion of implant 10 as wedge 150 is advanced along rod 142 towards the hinge at first end 12 of implant 10. Wedge 150 may comprise one or more lateral posts 155a that engage with channels 116c to provide an expansion mechanism configured to urge first endplate 110 away from second endplate 120 when wedge 150 is moved towards first end 12 of implant 10. Post 155a and channel 116c mechanism may also aid in making expansion of the implant 10 substantially reversible such that when wedge 150 is moved away from the hinge, lateral posts 155a are moved in a second direction in the lateral channels 116c to contract first endplate 110 towards second endplate 120 (which may result in implant 10 returning to the closed or unexpanded configuration shown generally in
In some embodiments, various designs may be used to optimize the interaction of wedge 150 with first endplate 110. Such configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as the lateral post 155a and channel 116c system described above that may combine to assist the ramps in expanding implant 10).
As described above, the expansion mechanism 140, 150 of implant 10 is secured to second endplate 120 such that first endplate 110 is urged away from expansion mechanism 140, 150 and second endplate 120 when wedge 150 is moved towards first end 12 of implant 10. In some embodiments, only a first end 145 of rod assembly 140 may be secured to first and/or second endplates 110, 120 such that the a second end 146 of rod assembly 140 may move relative to endplates 110, 120 as implant 10 is expanded or contracted. In such embodiments, lower surface 156 of wedge 150 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inside of second endplate 120 so as to gradually move the endplates 110, 120 away from each other as the wedge 150 is advanced along the rod 142. Inner surface 126 of second endplate 120 comprise ramps to engage lower surface 156 of wedge 150, and/or may comprise guidewalls with channels disposed therein to engage lateral posts extending from wedge 150, similar to those described above for the interaction of upper surface 158 of wedge 150 with inner surface 116 of first endplate 110. In some embodiments, various designs may be used to optimize the interaction of wedge 150 with endplates 110, 120. Such configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as the lateral post 155a and channel 116c system described above that may combine to assist the ramps in expanding the implant 10).
As wedge 150 moves towards the hinge, the mechanism loses mechanical advantage because the lever arm between the wedge and hinge joint decreases during expansion. This provides increased force feedback to a medical practitioner using implant 10, giving the medical practitioner a better feel of anatomical constraints. To supplement the expansion force, implant 10 may be specifically paired or used with other surgical instruments that manipulate the spine. These surgical instruments include, for example, surgical tables, patient positioning frames, and the like, that manipulate the patient and may for example further facilitate and/or adjust access to one or more disc spaces by bending the spine of a patient in various directions and adjusting the orientation of the patient to ease or facilitate access to the spinal surgical location(s). Exemplary surgical tables, patient positioning frames, and the like, and related methods of using them include those described in, e.g., U.S. patent application Ser. Nos. 15/239,239, 15/239,256, 15/337,157, 15/638,802, 15/639,080, 15/672,005, and 15/674,456, all incorporated herein by reference in their entirety.
In some embodiments, second end 146 of rod 142 may comprise an interface 144 configured to be operably engaged by a drive shaft (not shown) to rotate rod 142. Rod interface 144 may comprise a drive receptacle configured to cooperate with an implant-engaging end of the drive shaft. The drive connection between the driver shaft and rod interface 144 may comprise a variety of drive interfaces including but not limited to: multi-lobular drives; hexalobular drives; cross or Phillips head drives; straight or “flat head” drives; square or other polygonal drives; and/or combinations thereof. In other embodiments, first end 145 of rod assembly 140 (via rod 142 or securing pin 143) may further comprise an interface configured to be operably engaged by a drive shaft to rotate rod assembly 140. In this way, implants of the present disclosure may be expanded from both an anterior/oblique and posterior approach.
In some embodiments, implant 10 may further comprise vertebral endplate engagement components 170 which are configured to engage the vertebral endplate as the implant 10 is expanding. In some embodiments, vertebral endplate engagement components 170 may be claw- or hook-shaped. It is contemplated that vertebral endplate engagement components 170 may comprise various configurations suitable to engage the vertebral endplate to decrease or prevent potential migration or expulsion of the device from the intervertebral space. As shown in
Although
The system may also further comprise an expandable spinal implant 10 configured to be operably engaged with the insertion instrument 40 using a variety of mechanisms. As described herein, second end 14 of implant 10 may be configured to receive the tool end of insertion instrument 40 to manipulate expandable implant 10. In one embodiment, second end 124 of second endplate 120 of implant 10 comprises attachment apertures 124b disposed laterally adjacent to aperture 124a. These apertures 124b may be spaced and angled relative to mid-longitudinal axis L1-L1 of implant 10 as desired for particular surgical techniques. In some embodiments, apertures 124b may be parallel to mid-longitudinal axis L1-L1 of implant 10. In the depicted embodiment, the axis of apertures 124b is angled at approximately 15 degrees relative to mid-longitudinal axis L1-L1. Apertures 124b may comprise an inner threaded surface for engaging the threaded outer surface on the implant engaging end of attachment shaft 411. In other embodiments, the implant engaging end of attachment shaft 411 may interact with tabs or slots defined by one or both of endplates 110, 120. The attachment shaft 411 may be coaxially placed within the attachment cannula 410 and rotatable therein using the manual end of the attachment cannula (not shown). The manual end of the attachment shaft 411 may comprise a keyed or faceted surface configured for engagement with a quick-release handle (not shown) or a powered driver (not shown) for rotating attachment shaft 411.
In some embodiments, as shown in
The endplates 210, 220 may be operably engaged via a hinge mechanism located near or on the first ends 212 and 222. For example, first end 212 of first endplate 210 may comprise first and second hinge protrusions 217 extending along at least a portion of the length of first end 212 perpendicular to mid-longitudinal axis L2-L2. In some embodiments, first and second hinge protrusions are cylindrical and extend from lateral side surfaces 215 towards the mid-longitudinal axis L2-L2, and further comprise lumen 217b extending therethrough. First end 222 of second endplate 220 may also comprise a hinge protrusion 227. In some embodiments, hinge protrusion 227 is cylindrical and extends laterally along first end 122, and further comprises a lumen 227b extending therethrough. Lumens 217b, 227b of hinge protrusions 217, 227 may be co-axially aligned along a hinge axis H2-H2. A pin 230 may be disposed within lumens 217b, 227b of hinge protrusions 217, 227 to pivotably engage first endplate 210 to second endplate 220.
The expansion mechanism 240, 250 is designed to expand first endplate 210 and second endplate 220 away from each other as wedge 250 is translated towards second end 24 of implant 20 along rod assembly 240. Rod assembly 240 may be integrally formed, or may be formed of multiple components for, e.g., ease of manufacturing and/or assembly, like rod assembly 140 above. Rod assembly 240 may be secured to first and/or second endplates 210, 220 at a rod first end 245 such that a second rod end 246 may move relative to endplates 210, 220 as implant 20 is expanded or contracted (i.e., moved into an opened or closed configuration). In some embodiments, longitudinal axis E2-E2 of expansion mechanism 240, 250 may be aligned along mid-longitudinal axis L2-L2 of implant 20. In other embodiments, longitudinal axis E2-E2 of expansion mechanism 240, 250 may be offset from mid-longitudinal axis L2-L2 of implant 20, as depicted in
In some embodiments, upper surface 258 and lower surface 256 of wedge 250 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inside of endplates 210, 220 so as to gradually move endplates 210, 220 away from each other as wedge 250 is advanced along the rod assembly 240 towards second end 24 of implant 20. In some embodiments, various designs may be used to optimize the interaction of wedge 250 with endplates 210, 220. Such configurations may include, but are not limited to: sequential ramps or tapered surfaces with varying angles; shallow angle sequential ramps or tapered surfaces leading into higher angle sequential ramps or tapered surfaces, as well as other opening mechanisms (such as a lateral post and channel system). As shown in
In the depicted embodiment, second endplate 220 may comprise apertures 229 through which one or more screws 270 may be disposed to secure endplate 220 within an intervertebral space. Screws 270 may comprise a threaded outer surface 271 that engages with the inner surface of aperture 229, which may also be threaded. The engagement between threaded outer surface 271 and inner surface of aperture 229 may be via pitch lock, major/minor lock, or any other thread/pitch interface.
In some embodiments, second end 224 of second endplate 220 of implant 20 comprises inserter apertures 224b to engage with an insertion instrument 50 to form an expandable spinal implant system. As shown in
The endplates 310, 320 may be operably engaged via a hinge mechanism located near or on the first ends 312 and 322. For example, first end 312 of first endplate 310 may comprise first and second hinge protrusions 317 extending along at least a portion of the length of first end 312 perpendicular to mid-longitudinal axis L3-L3. In some embodiments, first and second hinge protrusions are cylindrical and extend from lateral side surfaces 315 towards the mid-longitudinal axis L3-L3, and further comprise lumen 317b extending therethrough. First end 322 of second endplate 320 may also comprise a hinge protrusion 327. In some embodiments, hinge protrusion 327 is cylindrical and extends laterally along first end 322, and further comprises a lumen 327b extending therethrough. Lumens 317b, 327b of hinge protrusions 317, 327 may be co-axially aligned along a hinge axis H3-H3. A pin 330 may be disposed within lumens 217b, 327b of hinge protrusions 317, 327 to pivotably engage first endplate 310 to second endplate 320.
The expansion mechanism 340, 350 is designed to expand first endplate 310 and second endplate 320 away from each other as wedge 350 is translated along rod assembly 340 towards second end 34 of implant 30. Rod assembly 340 may be integrally formed, or may be formed of multiple components for, e.g., ease of manufacturing and/or assembly, like rod assembly 140 above. Rod assembly 340 may be secured to first and/or second endplates 310, 320 at a first end 345 such that the second end 346 may move relative to endplates 310, 320 as implant 30 is expanded or contracted. In some embodiments, the longitudinal axis E3-E3 of expansion mechanism 340, 350 may be angled obliquely to mid-longitudinal axis L3-L3 at an angle θ, as depicted in
As described above for implants 10, 20, the second end 346 of rod assembly 340 may comprise an interface 344 configured to be operably engaged by a drive shaft (not shown) to rotate the rod assembly 340. Rod interface 344 may comprise a drive receptacle configured to cooperate with an implant engaging end of the drive shaft. The drive connection between the drive shaft and rod interface 344 may comprise a variety of drive interfaces including but not limited to: multi-lobular drives; hexalobular drives; cross or Phillips head drives; straight or “flat head” drives; square or other polygonal drives; and/or combinations thereof. In other embodiments, first end 345 of rod assembly 340 may further comprise an interface configured to be operably engaged by a drive shaft to rotate rod assembly 340. In this way, implants of the present disclosure may be expanded from both an anterior/oblique and posterior approach, as depicted in
In some embodiments, upper surface 358 and lower surface 356 of wedge 350 may be ramped or wedge-shaped and suitable for urging a complementary ramped or contoured surface on the inner surfaces 316, 326 of endplates 310, 320 so as to gradually move the endplates 310, 320 away from each other as wedge 350 is advanced along rod assembly 340. In some embodiments, various designs may be used to optimize the interaction of the wedge 350 with the endplates 210, 220. For example, as depicted in
In some embodiments, endplate 320 may comprise one or more tabs 329 comprising an aperture 329a through which one or more screws 370 may be disposed to secure endplate 320 within an intervertebral space. Screws 370 may comprise a threaded outer surface 371 that engages with the inner surface of aperture 329a, which may also be threaded. The engagement between threaded outer surface 371 and the inner surface of aperture 329a may be via pitch lock, major/minor lock, or any other thread/pitch interface.
In some embodiments, second end 324 of second endplate 320 of implant 30 comprises inserter apertures 324b to engage with an insertion instrument (not shown) to form an expandable spinal implant system. The number and arrangement of inserter apertures 324b allows the insertion instrument to be attached to implant 30 in multiple orientations. This provides user flexibility to place implant 30 within intervertebral space with first endplate 310 superior to second endplate 320 or with first endplate 310 inferior to second endplate 320 such that the tab 329 may be used to secure second endplate 320 in either the cephalad or caudad vertebral bodies.
Spinal implant systems of the present disclosure can be employed with a surgical arthrodesis procedure, such as, for example, an interbody fusion for treatment of an applicable condition or injury of an affected section of a spinal column and adjacent areas within a body, such as, for example, intervertebral disc space between adjacent vertebrae, and with additional surgical procedures and methods. In some embodiments, spinal implant systems can include an intervertebral implant that can be inserted with intervertebral disc space to space apart articular joint surfaces, provide support and maximize stabilization of vertebrae. In some embodiments, spinal implant systems may be employed with one or a plurality of vertebra.
A medical practitioner obtains access to a surgical site including vertebrae such as through incision and retraction of tissues. Spinal implant systems of the present disclosure can be used in any existing surgical method or technique including open surgery, mini-open surgery, minimally invasive surgery and percutaneous surgical implantation, whereby vertebrae are accessed through a mini-incision, retractor, tube or sleeve that provides a protected passageway to the area, including, for example, an expandable retractor wherein the sleeve is formed from multiple portions that may be moved apart or together and may be inserted with the portions closed or together and then expanded to allow for insertion of implants of larger size than the closed cross section of the unexpanded retractor portions. In one embodiment, the components of the spinal implant system are delivered through a surgical pathway to the surgical site along a surgical approach into intervertebral disc space between vertebrae. Various surgical approaches and pathways may be used. For example,
As will be appreciated by one of skill in the art, a preparation instrument (not shown) may be employed to remove disc tissue, fluids, adjacent tissues and/or bone, and scrape and/or remove tissue from endplate surfaces of a first vertebra and/or endplate surface of a second vertebra in preparation for or as part of the procedures utilizing a system of the present disclosure. In some embodiments, the size of implant 10, 20, 30 is selected after trialing using trialing instruments (not shown) that may approximate the size and configuration of the implants 10, 20, 30. In some embodiments, such trials may be fixed in size and/or be fitted with expansion mechanisms similar to the various implant 10, 20, 30 embodiments described herein. In some embodiments, implant 10 may be visualized by fluoroscopy and oriented before introduction into intervertebral disc space. Furthermore, the insertion instruments 40, 50 and implants 10, 20, 30 may be fitted with fiducial markers to enable image guided surgical navigation to be used prior to and/or during a procedure.
Components of a spinal implant system of the present disclosure including implant 10, 20, 30 can be delivered or implanted as a pre-assembled device or can be assembled in situ. Components of spinal implant system including implant 10, 20, 30 may be expanded, contracted, completely or partially revised, removed or replaced in situ. In some embodiments, one or all of the components of spinal implant system 10, 20, 30 can be delivered to the surgical site via mechanical manipulation and/or a free hand technique.
In some embodiments, the spinal implant system includes an agent, including but not limited to the bone growth promoting materials described herein, which may be disposed, packed, coated or layered within, on or about the components and/or surfaces of the spinal implant system. In some embodiments the bone growth promoting materials may be pre-packed in the interior of the implant, and/or may be packed during or after implantation of the implant via a tube, cannula, syringe or a combination of these or other access instruments and may be further tamped into the implant before, during or after implantation. In some embodiments, the agent may include bone growth promoting material to enhance fixation of implants 10, 20, 30 with bony structures. In some embodiments, the agent may include one or a plurality of therapeutic agents and/or pharmacological agents for release, including sustained release, to treat, for example, pain, inflammation and degeneration.
In one embodiment, implants 10, 20, 30 may include fastening elements, which may include locking structure, configured for fixation with vertebrae to secure joint surfaces and provide complementary stabilization and immobilization to a vertebral region. In some embodiments, locking structure may include fastening elements, such as, for example, rods, plates, clips, hooks, adhesives and/or flanges. In some embodiments, the components of spinal implant system 20, 30 can be used with screws to enhance fixation. The components of the spinal implant system can be made of radiolucent materials such as polymers. Radiopaque markers may be included for identification under x-ray, fluoroscopy, CT or other imaging techniques. The insertion instruments 40, 50 may be radiolucent and may optionally include markers added at the tip and/or along the length of one or both of insertion instruments 40, 50 and the tube to permit them to be seen on fluoroscopy/x-ray while advancing into the patient. If the implants 10, 20, 30 includes radiolucent markers placed near the end this may permit visualization of the proximity of the tip of the tube moving toward the second ends 14, 24, 34 of implants 10, 20, 30.
In some embodiments, the use of microsurgical, minimally-invasive and image guided technologies may be employed to access, view and repair spinal deterioration or damage, with the aid of spinal implant system. Upon completion of the procedure, the non-implanted components, surgical instruments and assemblies of spinal implant system may be removed and the incision is closed. In some embodiments, the various instruments disclosed may be provided with fiducial markers or other elements suitable for use with surgical navigation systems (including, but not limited to the STEALTHSTATION® Navigation system available from Medtronic), such that a surgeon may view a projected trajectory or insertion pathway of the implants 10, 20, 30 relative to a patient's anatomy in real time and/or in near-real time.
It will be understood that the various independent components of the expandable spinal implants 10, 20, 30, and insertion instruments 40, 50 described herein may be combined in different ways according to various embodiments.
It will be understood that various modifications may be made to the embodiments disclosed herein. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with the true scope and spirit of the invention being indicated by the following claims.
This application is a continuation of U.S. application Ser. No. 17/246,959 (now U.S. Pat. No. 11,806,250), entitled “EXPANDABLE SPINAL IMPLANT SYSTEM AND METHOD OF USING SAME”, filed May 3, 2021, which is a continuation in-part of U.S. application Ser. No. 16/282,654 (now U.S. Pat. No. 11,020,239), entitled “EXPANDABLE SPINAL SYSTEM AND METHOD OF USING SAME”, filed Feb. 22, 2019, which claims benefit to U.S. Provisional Patent Application Ser. No. 62/633,952, entitled “EXPANDABLE SPINAL IMPLANT SYSTEM AND METHOD OF USING SAME”, filed Feb. 22, 2018. The entire disclosure of each is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
1677337 | Grove | Jul 1928 | A |
3847154 | Nordin | Nov 1974 | A |
4553273 | Wu | Nov 1985 | A |
4636217 | Ogilvie et al. | Jan 1987 | A |
4716894 | Lazzeri et al. | Jan 1988 | A |
4759769 | Hedman et al. | Jul 1988 | A |
5059193 | Kuslich | Oct 1991 | A |
5171278 | Pisharodi | Dec 1992 | A |
5228811 | Potter | Jul 1993 | A |
5284483 | Johnson et al. | Feb 1994 | A |
5336223 | Rogers | Aug 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5522899 | Michelson | Jun 1996 | A |
5554191 | Lahille et al. | Sep 1996 | A |
5575790 | Chen et al. | Nov 1996 | A |
5609635 | Michelson | Mar 1997 | A |
5653762 | Pisharodi | Aug 1997 | A |
5653763 | Errico et al. | Aug 1997 | A |
5658336 | Pisharodi | Aug 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5693100 | Pisharodi | Dec 1997 | A |
5697977 | Pisharodi | Dec 1997 | A |
5702391 | Lin | Dec 1997 | A |
5702453 | Rabbe et al. | Dec 1997 | A |
5702455 | Saggar | Dec 1997 | A |
5797918 | McGuire et al. | Aug 1998 | A |
5800550 | Sertich | Sep 1998 | A |
5865848 | Baker | Feb 1999 | A |
5893890 | Pisharodi | Apr 1999 | A |
5931777 | Sava | Aug 1999 | A |
5941885 | Jackson | Aug 1999 | A |
5971987 | Huxel et al. | Oct 1999 | A |
5980522 | Koros et al. | Nov 1999 | A |
6045579 | Hochshuler et al. | Apr 2000 | A |
6074343 | Nathanson et al. | Jun 2000 | A |
6080193 | Hochshuler et al. | Jun 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6102949 | Biedermann et al. | Aug 2000 | A |
6102950 | Vaccaro | Aug 2000 | A |
6106557 | Robioneck et al. | Aug 2000 | A |
6113638 | Williams et al. | Sep 2000 | A |
6117174 | Nolan | Sep 2000 | A |
6132465 | Ray et al. | Oct 2000 | A |
6159211 | Boriani et al. | Dec 2000 | A |
6159244 | Suddaby | Dec 2000 | A |
6176882 | Biedermann et al. | Jan 2001 | B1 |
6179873 | Zientek | Jan 2001 | B1 |
6190414 | Young et al. | Feb 2001 | B1 |
6193757 | Foley et al. | Feb 2001 | B1 |
6217579 | Koros | Apr 2001 | B1 |
6245108 | Biscup | Jun 2001 | B1 |
6309421 | Pisharodi | Oct 2001 | B1 |
6342074 | Simpson | Jan 2002 | B1 |
6371989 | Chauvin et al. | Apr 2002 | B1 |
6395031 | Foley et al. | May 2002 | B1 |
6423063 | Bonutti | Jul 2002 | B1 |
6432106 | Fraser | Aug 2002 | B1 |
6436140 | Liu et al. | Aug 2002 | B1 |
6443989 | Jackson | Sep 2002 | B1 |
6443990 | Aebi et al. | Sep 2002 | B1 |
6454806 | Cohen et al. | Sep 2002 | B1 |
6454807 | Jackson | Sep 2002 | B1 |
6461359 | Tribus et al. | Oct 2002 | B1 |
6491724 | Ferree | Dec 2002 | B1 |
6520991 | Huene | Feb 2003 | B2 |
6520993 | James et al. | Feb 2003 | B2 |
6524238 | Velikaris et al. | Feb 2003 | B2 |
6527803 | Crozet et al. | Mar 2003 | B1 |
6562074 | Gerbec et al. | May 2003 | B2 |
6576016 | Hochshuler et al. | Jun 2003 | B1 |
6623525 | Ralph et al. | Sep 2003 | B2 |
6629998 | Lin | Oct 2003 | B1 |
6635086 | Lin | Oct 2003 | B2 |
6648917 | Gerbec et al. | Nov 2003 | B2 |
6676703 | Biscup | Jan 2004 | B2 |
6685742 | Jackson | Feb 2004 | B1 |
6723126 | Berry | Apr 2004 | B1 |
6770096 | Bolger et al. | Aug 2004 | B2 |
6773460 | Jackson | Aug 2004 | B2 |
6821298 | Jackson | Nov 2004 | B1 |
6835206 | Jackson | Dec 2004 | B2 |
6849093 | Michelson | Feb 2005 | B2 |
6852129 | Gerbec et al. | Feb 2005 | B2 |
6863673 | Gerbec et al. | Mar 2005 | B2 |
6923814 | Hildebrand et al. | Aug 2005 | B1 |
6926737 | Jackson | Aug 2005 | B2 |
6953477 | Berry | Oct 2005 | B2 |
6964687 | Bernard et al. | Nov 2005 | B1 |
6974480 | Messerli et al. | Dec 2005 | B2 |
6984234 | Bray | Jan 2006 | B2 |
7112222 | Fraser et al. | Sep 2006 | B2 |
7135043 | Nakahara et al. | Nov 2006 | B2 |
7137997 | Paul | Nov 2006 | B2 |
7172627 | Fiere et al. | Feb 2007 | B2 |
7188626 | Foley et al. | Mar 2007 | B2 |
7204853 | Gordon et al. | Apr 2007 | B2 |
7232464 | Mathieu et al. | Jun 2007 | B2 |
7238203 | Bagga et al. | Jul 2007 | B2 |
7255700 | Kaiser et al. | Aug 2007 | B2 |
7316532 | Matthys-Mark | Jan 2008 | B2 |
7316714 | Gordon et al. | Jan 2008 | B2 |
7407483 | Perez-Cruet et al. | Aug 2008 | B2 |
7481766 | Lee et al. | Jan 2009 | B2 |
7491168 | Raymond et al. | Feb 2009 | B2 |
7537565 | Bass | May 2009 | B2 |
7618456 | Mathieu et al. | Nov 2009 | B2 |
7625394 | Molz, IV et al. | Dec 2009 | B2 |
7635366 | Abdou | Dec 2009 | B2 |
7637909 | Lechot et al. | Dec 2009 | B2 |
7655046 | Dryer et al. | Feb 2010 | B2 |
7678148 | Peterman | Mar 2010 | B2 |
7703727 | Selness | Apr 2010 | B2 |
7708778 | Gordon et al. | May 2010 | B2 |
7708779 | Edie et al. | May 2010 | B2 |
7727280 | McLuen | Jun 2010 | B2 |
7753958 | Gordon et al. | Jul 2010 | B2 |
7780594 | Hutton | Aug 2010 | B2 |
7806932 | Webb et al. | Oct 2010 | B2 |
7815682 | Peterson et al. | Oct 2010 | B1 |
7819801 | Miles et al. | Oct 2010 | B2 |
7824428 | Mikkonen et al. | Nov 2010 | B2 |
7828849 | Lim | Nov 2010 | B2 |
7846167 | Garcia et al. | Dec 2010 | B2 |
7846207 | Lechmann et al. | Dec 2010 | B2 |
7850731 | Brittan et al. | Dec 2010 | B2 |
7850733 | Baynham et al. | Dec 2010 | B2 |
7862616 | Lechmann et al. | Jan 2011 | B2 |
7875076 | Mathieu et al. | Jan 2011 | B2 |
7883542 | Zipnick | Feb 2011 | B2 |
7892173 | Miles et al. | Feb 2011 | B2 |
7909869 | Gordon et al. | Mar 2011 | B2 |
7914559 | Carls et al. | Mar 2011 | B2 |
7967821 | Sicvol et al. | Jun 2011 | B2 |
7981031 | Frasier et al. | Jul 2011 | B2 |
8016836 | Corrao et al. | Sep 2011 | B2 |
8062375 | Glerum et al. | Nov 2011 | B2 |
8105382 | Olmos et al. | Jan 2012 | B2 |
8118870 | Gordon et al. | Feb 2012 | B2 |
8118871 | Gordon et al. | Feb 2012 | B2 |
8123810 | Gordon et al. | Feb 2012 | B2 |
8147550 | Gordon et al. | Apr 2012 | B2 |
8172903 | Gordon et al. | May 2012 | B2 |
8182539 | Tyber et al. | May 2012 | B2 |
8257442 | Edie et al. | Sep 2012 | B2 |
8262570 | White et al. | Sep 2012 | B2 |
8262662 | Beardsley et al. | Sep 2012 | B2 |
8262710 | Freedman et al. | Sep 2012 | B2 |
8287597 | Pimenta et al. | Oct 2012 | B1 |
8303498 | Miles et al. | Nov 2012 | B2 |
8303658 | Peterman | Nov 2012 | B2 |
8303663 | Jimenez et al. | Nov 2012 | B2 |
8317866 | Palmatier et al. | Nov 2012 | B2 |
8323185 | Perez-Cruet et al. | Dec 2012 | B2 |
8328872 | Duffield et al. | Dec 2012 | B2 |
8343048 | Warren, Jr. | Jan 2013 | B2 |
8353826 | Weiman | Jan 2013 | B2 |
8355780 | Miles et al. | Jan 2013 | B2 |
8382842 | Greenhalgh et al. | Feb 2013 | B2 |
8388527 | Miles et al. | Mar 2013 | B2 |
8398713 | Weiman | Mar 2013 | B2 |
8403990 | Dryer et al. | Mar 2013 | B2 |
8419797 | Biedermann et al. | Apr 2013 | B2 |
8425528 | Berry et al. | Apr 2013 | B2 |
8435298 | Weiman | May 2013 | B2 |
8480576 | Sandhu | Jul 2013 | B2 |
8496706 | Ragab et al. | Jul 2013 | B2 |
8500634 | Miles et al. | Aug 2013 | B2 |
8506635 | Palmatier et al. | Aug 2013 | B2 |
8517935 | Marchek et al. | Aug 2013 | B2 |
8518120 | Glerum et al. | Aug 2013 | B2 |
8535380 | Greenhalgh et al. | Sep 2013 | B2 |
8550994 | Miles et al. | Oct 2013 | B2 |
8556808 | Miles et al. | Oct 2013 | B2 |
8556979 | Glerum et al. | Oct 2013 | B2 |
8579809 | Parker | Nov 2013 | B2 |
8579898 | Prandi et al. | Nov 2013 | B2 |
8579979 | Edie et al. | Nov 2013 | B2 |
8579981 | Lim et al. | Nov 2013 | B2 |
8602984 | Raymond et al. | Dec 2013 | B2 |
8608785 | Reed et al. | Dec 2013 | B2 |
8628576 | Triplett et al. | Jan 2014 | B2 |
8628578 | Miller et al. | Jan 2014 | B2 |
8632595 | Weiman | Jan 2014 | B2 |
8641768 | Duffield et al. | Feb 2014 | B2 |
8647386 | Gordon et al. | Feb 2014 | B2 |
8663329 | Ernst | Mar 2014 | B2 |
8668419 | Hardt et al. | Mar 2014 | B2 |
8668715 | Sandhu | Mar 2014 | B2 |
8679183 | Glerum et al. | Mar 2014 | B2 |
8685095 | Miller et al. | Apr 2014 | B2 |
8685098 | Glerum et al. | Apr 2014 | B2 |
8696559 | Miles et al. | Apr 2014 | B2 |
8709083 | Duffield et al. | Apr 2014 | B2 |
8709085 | Lechmann et al. | Apr 2014 | B2 |
8709086 | Glerum | Apr 2014 | B2 |
8715285 | Lewis et al. | May 2014 | B2 |
8715353 | Bagga et al. | May 2014 | B2 |
8740983 | Arnold et al. | Jun 2014 | B1 |
8753271 | Miles et al. | Jun 2014 | B1 |
8753396 | Hockett et al. | Jun 2014 | B1 |
8764649 | Miles et al. | Jul 2014 | B2 |
8771360 | Jimenez et al. | Jul 2014 | B2 |
8778025 | Ragab et al. | Jul 2014 | B2 |
8778027 | Medina | Jul 2014 | B2 |
8795366 | Varela | Aug 2014 | B2 |
8808305 | Kleiner | Aug 2014 | B2 |
8827902 | Dietze, Jr. et al. | Sep 2014 | B2 |
8828085 | Jensen | Sep 2014 | B1 |
8840668 | Donahoe et al. | Sep 2014 | B1 |
8845731 | Weiman | Sep 2014 | B2 |
8845732 | Weiman | Sep 2014 | B2 |
8845734 | Weiman | Sep 2014 | B2 |
8852252 | Venturini et al. | Oct 2014 | B2 |
8852282 | Farley et al. | Oct 2014 | B2 |
8864833 | Glerum et al. | Oct 2014 | B2 |
8882813 | Jones et al. | Nov 2014 | B2 |
8888853 | Glerum et al. | Nov 2014 | B2 |
8894708 | Thalgott et al. | Nov 2014 | B2 |
8894711 | Varela | Nov 2014 | B2 |
8894712 | Varela | Nov 2014 | B2 |
8906095 | Christensen et al. | Dec 2014 | B2 |
8920500 | Pimenta et al. | Dec 2014 | B1 |
8926704 | Glerum et al. | Jan 2015 | B2 |
8936641 | Cain | Jan 2015 | B2 |
8940049 | Jimenez et al. | Jan 2015 | B1 |
8968363 | Weiman et al. | Mar 2015 | B2 |
8986344 | Sandhu | Mar 2015 | B2 |
8992425 | Karpowicz et al. | Mar 2015 | B2 |
8992544 | Sasing | Mar 2015 | B2 |
9005292 | Melamed | Apr 2015 | B2 |
9005293 | Moskowitz et al. | Apr 2015 | B2 |
9005295 | Kueenzi et al. | Apr 2015 | B2 |
9017412 | Wolters et al. | Apr 2015 | B2 |
9034045 | Davenport et al. | May 2015 | B2 |
9050146 | Woolley et al. | Jun 2015 | B2 |
9050194 | Thibodeau | Jun 2015 | B2 |
9060877 | Kleiner | Jun 2015 | B2 |
9072548 | Matityahu | Jul 2015 | B2 |
9072563 | Garcia et al. | Jul 2015 | B2 |
9084591 | Reglos et al. | Jul 2015 | B2 |
9113854 | Ellman | Aug 2015 | B2 |
9119730 | Glerum et al. | Sep 2015 | B2 |
9125757 | Weiman | Sep 2015 | B2 |
9132021 | Mermuys et al. | Sep 2015 | B2 |
9138217 | Smith et al. | Sep 2015 | B2 |
9138330 | Hansell et al. | Sep 2015 | B2 |
9138331 | Aferzon | Sep 2015 | B2 |
9149367 | Davenport et al. | Oct 2015 | B2 |
9155628 | Glerum et al. | Oct 2015 | B2 |
9155631 | Seifert et al. | Oct 2015 | B2 |
9161841 | Kana et al. | Oct 2015 | B2 |
9179903 | Cianfrani et al. | Nov 2015 | B2 |
9179952 | Biedermann et al. | Nov 2015 | B2 |
9186193 | Kleiner et al. | Nov 2015 | B2 |
9186258 | Davenport et al. | Nov 2015 | B2 |
9192482 | Pimenta et al. | Nov 2015 | B1 |
9192483 | Radcliffe et al. | Nov 2015 | B1 |
9198772 | Weiman | Dec 2015 | B2 |
9204972 | Weiman et al. | Dec 2015 | B2 |
9204974 | Glerum et al. | Dec 2015 | B2 |
9211194 | Bagga et al. | Dec 2015 | B2 |
9211196 | Glerum et al. | Dec 2015 | B2 |
9216095 | Glerum et al. | Dec 2015 | B2 |
9226836 | Glerum | Jan 2016 | B2 |
9233007 | Sungarian et al. | Jan 2016 | B2 |
9233009 | Gray et al. | Jan 2016 | B2 |
9233010 | Thalgott et al. | Jan 2016 | B2 |
9259327 | Niemiec et al. | Feb 2016 | B2 |
9271846 | Lim et al. | Mar 2016 | B2 |
9308099 | Triplett et al. | Apr 2016 | B2 |
9320610 | Alheidt et al. | Apr 2016 | B2 |
9351845 | Pimenta et al. | May 2016 | B1 |
9351848 | Glerum et al. | May 2016 | B2 |
9357909 | Perez-Cruet et al. | Jun 2016 | B2 |
9358126 | Glerum et al. | Jun 2016 | B2 |
9358127 | Duffield et al. | Jun 2016 | B2 |
9358128 | Glerum et al. | Jun 2016 | B2 |
9358129 | Weiman | Jun 2016 | B2 |
9364341 | Gowan | Jun 2016 | B2 |
9364343 | Duffield et al. | Jun 2016 | B2 |
9370434 | Weiman | Jun 2016 | B2 |
9370435 | Walkenhorst et al. | Jun 2016 | B2 |
9381008 | Thornburg | Jul 2016 | B2 |
9386916 | Predick et al. | Jul 2016 | B2 |
9387092 | Mermuys et al. | Jul 2016 | B2 |
9402673 | Cormier et al. | Aug 2016 | B2 |
9402739 | Weiman et al. | Aug 2016 | B2 |
9408596 | Blain | Aug 2016 | B2 |
9408708 | Greenhalgh | Aug 2016 | B2 |
9414828 | Abidin et al. | Aug 2016 | B2 |
9414934 | Cain | Aug 2016 | B2 |
9414937 | Carlson et al. | Aug 2016 | B2 |
9421110 | Masson et al. | Aug 2016 | B2 |
9427331 | Arnin | Aug 2016 | B2 |
9445919 | Palmatier et al. | Sep 2016 | B2 |
9452063 | Glerum et al. | Sep 2016 | B2 |
9456903 | Glerum et al. | Oct 2016 | B2 |
9456906 | Gray et al. | Oct 2016 | B2 |
9468405 | Miles et al. | Oct 2016 | B2 |
9474622 | McLaughlin et al. | Oct 2016 | B2 |
9474625 | Weiman | Oct 2016 | B2 |
9480573 | Perloff et al. | Nov 2016 | B2 |
9480576 | Pepper et al. | Nov 2016 | B2 |
9480579 | Davenport et al. | Nov 2016 | B2 |
9486133 | Lee et al. | Nov 2016 | B2 |
9486325 | Davenport et al. | Nov 2016 | B2 |
9486327 | Martynova et al. | Nov 2016 | B2 |
9486328 | Jimenez et al. | Nov 2016 | B2 |
9492287 | Glerum et al. | Nov 2016 | B2 |
9492288 | Wagner et al. | Nov 2016 | B2 |
9492289 | Davenport et al. | Nov 2016 | B2 |
9498349 | Patterson et al. | Nov 2016 | B2 |
9510954 | Glerum et al. | Dec 2016 | B2 |
9517098 | Anderson | Dec 2016 | B2 |
9522070 | Flower et al. | Dec 2016 | B2 |
9526620 | Slivka et al. | Dec 2016 | B2 |
9526625 | Cain | Dec 2016 | B2 |
9532821 | Moskowitz et al. | Jan 2017 | B2 |
9539103 | McLaughlin et al. | Jan 2017 | B2 |
9539108 | Glerum et al. | Jan 2017 | B2 |
9545320 | Padovani et al. | Jan 2017 | B2 |
9549723 | Hynes et al. | Jan 2017 | B2 |
9549824 | McAfee | Jan 2017 | B2 |
9561116 | Weiman et al. | Feb 2017 | B2 |
9566163 | Suddaby et al. | Feb 2017 | B2 |
9566166 | Parry et al. | Feb 2017 | B2 |
9566168 | Glerum et al. | Feb 2017 | B2 |
9572560 | Mast et al. | Feb 2017 | B2 |
9572677 | Davenport et al. | Feb 2017 | B2 |
9572681 | Mathieu et al. | Feb 2017 | B2 |
9579124 | Gordon et al. | Feb 2017 | B2 |
9579139 | Cormier et al. | Feb 2017 | B2 |
9579213 | Bal et al. | Feb 2017 | B2 |
9585649 | Blain et al. | Mar 2017 | B2 |
9585762 | Suddaby et al. | Mar 2017 | B2 |
9585766 | Robinson | Mar 2017 | B2 |
9585767 | Robinson | Mar 2017 | B2 |
9592129 | Slivka et al. | Mar 2017 | B2 |
9597195 | Cain | Mar 2017 | B2 |
9603643 | Reed et al. | Mar 2017 | B2 |
9603713 | Moskowitz et al. | Mar 2017 | B2 |
9603717 | Ibarra et al. | Mar 2017 | B2 |
9615818 | Baudouin et al. | Apr 2017 | B2 |
9615936 | Duffield et al. | Apr 2017 | B2 |
9622732 | Martinelli et al. | Apr 2017 | B2 |
9622875 | Moskowitz et al. | Apr 2017 | B2 |
9622876 | Greenhalgh et al. | Apr 2017 | B1 |
9629729 | Grimberg, Jr. et al. | Apr 2017 | B2 |
9636097 | Bass | May 2017 | B2 |
9642720 | Radcliffe et al. | May 2017 | B2 |
9649198 | Wolters et al. | May 2017 | B2 |
9655746 | Seifert | May 2017 | B2 |
9655747 | Glerum et al. | May 2017 | B2 |
9662224 | Weiman et al. | May 2017 | B2 |
9668784 | Brumfield et al. | Jun 2017 | B2 |
9668876 | Blain et al. | Jun 2017 | B2 |
9668879 | Jimenez et al. | Jun 2017 | B2 |
9675465 | Padovani et al. | Jun 2017 | B2 |
9675467 | Duffield et al. | Jun 2017 | B2 |
9675468 | Jensen | Jun 2017 | B1 |
9693871 | Richerme et al. | Jul 2017 | B2 |
9700428 | Niemiec et al. | Jul 2017 | B2 |
9707092 | Davenport et al. | Jul 2017 | B2 |
9713536 | Foley et al. | Jul 2017 | B2 |
9717601 | Miller | Aug 2017 | B2 |
9730684 | Beale et al. | Aug 2017 | B2 |
9730806 | Capote | Aug 2017 | B2 |
9737288 | Karpowicz et al. | Aug 2017 | B2 |
9750617 | Lim et al. | Sep 2017 | B2 |
9750618 | Daffinson et al. | Sep 2017 | B1 |
9757249 | Radcliffe et al. | Sep 2017 | B2 |
9763722 | Roybal | Sep 2017 | B2 |
9770343 | Weiman | Sep 2017 | B2 |
9782265 | Weiman et al. | Oct 2017 | B2 |
9788971 | Stein | Oct 2017 | B1 |
9795370 | O'Connell et al. | Oct 2017 | B2 |
9795371 | Miles et al. | Oct 2017 | B2 |
9801733 | Wolters et al. | Oct 2017 | B2 |
9801734 | Stein et al. | Oct 2017 | B1 |
9808352 | Suddaby et al. | Nov 2017 | B2 |
9826966 | Mast et al. | Nov 2017 | B2 |
9827024 | Cormier et al. | Nov 2017 | B2 |
9827107 | Arnin | Nov 2017 | B1 |
9833333 | Duffield et al. | Dec 2017 | B2 |
9833336 | Davenport et al. | Dec 2017 | B2 |
9839527 | Robinson | Dec 2017 | B2 |
9839528 | Weiman et al. | Dec 2017 | B2 |
9848993 | Moskowitz et al. | Dec 2017 | B2 |
9848996 | Faulhaber | Dec 2017 | B2 |
9855151 | Weiman | Jan 2018 | B2 |
9867715 | McLaughlin et al. | Jan 2018 | B2 |
9872779 | Miller et al. | Jan 2018 | B2 |
9889019 | Rogers et al. | Feb 2018 | B2 |
9907671 | Fessler | Mar 2018 | B2 |
9907673 | Weiman et al. | Mar 2018 | B2 |
9918709 | Sandhu | Mar 2018 | B2 |
9924859 | Lee et al. | Mar 2018 | B2 |
9924940 | Moskowitz et al. | Mar 2018 | B2 |
9925062 | Glerum et al. | Mar 2018 | B2 |
9925064 | Duffield et al. | Mar 2018 | B2 |
9931223 | Cain | Apr 2018 | B2 |
9937053 | Melkent et al. | Apr 2018 | B2 |
9943342 | Tanaka et al. | Apr 2018 | B2 |
9943418 | Davenport et al. | Apr 2018 | B2 |
9949775 | Reed et al. | Apr 2018 | B2 |
9949841 | Glerum et al. | Apr 2018 | B2 |
9956087 | Seifert et al. | May 2018 | B2 |
9962202 | Anderson | May 2018 | B2 |
9962270 | Alheidt et al. | May 2018 | B2 |
9962271 | Glerum | May 2018 | B2 |
9962272 | Daffinson et al. | May 2018 | B1 |
9968461 | Zappacosta et al. | May 2018 | B2 |
9968462 | Weiman | May 2018 | B2 |
9974531 | Miles et al. | May 2018 | B2 |
9974662 | Hessler et al. | May 2018 | B2 |
9974664 | Emerick et al. | May 2018 | B2 |
9980825 | Nichols et al. | May 2018 | B2 |
9980826 | Martynova et al. | May 2018 | B2 |
9987141 | Duffield et al. | Jun 2018 | B2 |
9987143 | Robinson et al. | Jun 2018 | B2 |
9987144 | Seifert et al. | Jun 2018 | B2 |
9987146 | Lentner et al. | Jun 2018 | B1 |
9993239 | Karpowicz et al. | Jun 2018 | B2 |
9993350 | Cain | Jun 2018 | B2 |
10004607 | Weiman et al. | Jun 2018 | B2 |
10016282 | Seifert et al. | Jul 2018 | B2 |
10016284 | Moskowitz et al. | Jul 2018 | B2 |
10022239 | Lentner et al. | Jul 2018 | B1 |
10028842 | Gray et al. | Jul 2018 | B2 |
10034765 | Blain et al. | Jul 2018 | B2 |
10034769 | Baynham | Jul 2018 | B2 |
10034771 | Capote et al. | Jul 2018 | B2 |
10034772 | Glerum et al. | Jul 2018 | B2 |
10034773 | McLaughlin et al. | Jul 2018 | B2 |
10039539 | Friedrich et al. | Aug 2018 | B2 |
10039650 | Lamborne et al. | Aug 2018 | B2 |
10052214 | Jimenez et al. | Aug 2018 | B2 |
10058431 | Tyber et al. | Aug 2018 | B2 |
10060469 | Jimenez et al. | Aug 2018 | B2 |
10070852 | Mast et al. | Sep 2018 | B2 |
10076320 | Mast et al. | Sep 2018 | B2 |
10076423 | Miller et al. | Sep 2018 | B2 |
10080666 | Suddaby et al. | Sep 2018 | B2 |
10080669 | Davenport et al. | Sep 2018 | B2 |
10085846 | Grotz | Oct 2018 | B2 |
10085849 | Weiman et al. | Oct 2018 | B2 |
10092417 | Weiman et al. | Oct 2018 | B2 |
10098758 | Matthews et al. | Oct 2018 | B2 |
10098759 | Weiman | Oct 2018 | B2 |
10111755 | Foley et al. | Oct 2018 | B2 |
10111758 | Robinson | Oct 2018 | B2 |
10117754 | Davenport et al. | Nov 2018 | B2 |
10117755 | Emerick et al. | Nov 2018 | B2 |
10137002 | Padovani et al. | Nov 2018 | B2 |
10137006 | Dewey et al. | Nov 2018 | B2 |
10137007 | Dewey et al. | Nov 2018 | B2 |
10137009 | Weiman et al. | Nov 2018 | B2 |
10149671 | Predick et al. | Dec 2018 | B2 |
10149710 | Tanaka et al. | Dec 2018 | B2 |
10154781 | Weiman | Dec 2018 | B2 |
10154912 | Glerum | Dec 2018 | B2 |
10154914 | Robinson | Dec 2018 | B2 |
10159584 | Carnes et al. | Dec 2018 | B2 |
10166117 | Daffinson et al. | Jan 2019 | B1 |
10172515 | Lee et al. | Jan 2019 | B2 |
10172652 | Woolley et al. | Jan 2019 | B2 |
10178987 | Predick et al. | Jan 2019 | B2 |
10179053 | Zappacosta et al. | Jan 2019 | B2 |
10182922 | Nichols et al. | Jan 2019 | B2 |
10188527 | Rogers et al. | Jan 2019 | B2 |
10195050 | Palmatier et al. | Feb 2019 | B2 |
10201431 | Slater et al. | Feb 2019 | B2 |
10213192 | Capote | Feb 2019 | B2 |
10213193 | Karpowicz et al. | Feb 2019 | B2 |
10219798 | Capote | Mar 2019 | B2 |
10219913 | Matthews et al. | Mar 2019 | B2 |
10219914 | Faulhaber | Mar 2019 | B2 |
10219915 | Stein | Mar 2019 | B1 |
10226356 | Grotz | Mar 2019 | B2 |
10226359 | Glerum et al. | Mar 2019 | B2 |
10238375 | O'Connell et al. | Mar 2019 | B2 |
10238383 | Moskowitz et al. | Mar 2019 | B2 |
10238503 | Branch et al. | Mar 2019 | B2 |
10245015 | Predick et al. | Apr 2019 | B2 |
10251643 | Moskowitz et al. | Apr 2019 | B2 |
10265191 | Lim et al. | Apr 2019 | B2 |
10278686 | Baudouin et al. | May 2019 | B2 |
10278786 | Friedrich et al. | May 2019 | B2 |
10278830 | Walker et al. | May 2019 | B1 |
10278831 | Sandul | May 2019 | B2 |
10278832 | Nichols et al. | May 2019 | B2 |
10285680 | Friedrich et al. | May 2019 | B2 |
10285819 | Greenhalgh | May 2019 | B2 |
10285824 | Robinson | May 2019 | B2 |
10292828 | Greenhalgh | May 2019 | B2 |
10299777 | Mast et al. | May 2019 | B2 |
10299934 | Seifert et al. | May 2019 | B2 |
10299937 | McAfee | May 2019 | B2 |
10307268 | Moskowitz et al. | Jun 2019 | B2 |
10314622 | Brumfield et al. | Jun 2019 | B2 |
10314719 | Hessler et al. | Jun 2019 | B2 |
10322007 | Masson et al. | Jun 2019 | B2 |
10322009 | Aghayev et al. | Jun 2019 | B2 |
10327909 | Baynham | Jun 2019 | B2 |
10327912 | Suddaby | Jun 2019 | B1 |
10327917 | Glerum et al. | Jun 2019 | B2 |
10342675 | Alheidt | Jul 2019 | B2 |
10350085 | Glerum et al. | Jul 2019 | B2 |
10357233 | Miles et al. | Jul 2019 | B2 |
10363142 | McClintock et al. | Jul 2019 | B2 |
10363144 | Overes et al. | Jul 2019 | B2 |
10369004 | Faulhaber | Aug 2019 | B2 |
10369008 | Jimenez et al. | Aug 2019 | B2 |
10369010 | Robinson et al. | Aug 2019 | B2 |
10369012 | Fessler | Aug 2019 | B2 |
10376377 | Seifert et al. | Aug 2019 | B2 |
10390962 | Weiman | Aug 2019 | B2 |
10390964 | Faulhaber | Aug 2019 | B2 |
10398563 | Engstrom | Sep 2019 | B2 |
10398566 | Olmos et al. | Sep 2019 | B2 |
10413419 | Thibodeau | Sep 2019 | B2 |
10413422 | Flower et al. | Sep 2019 | B2 |
10413423 | Overes et al. | Sep 2019 | B2 |
10426450 | Vogel et al. | Oct 2019 | B2 |
10426633 | Moskowitz et al. | Oct 2019 | B2 |
10426634 | Al-Jazaeri et al. | Oct 2019 | B1 |
10441430 | Ludwig et al. | Oct 2019 | B2 |
10449056 | Cain | Oct 2019 | B2 |
10456122 | Koltz et al. | Oct 2019 | B2 |
10470894 | Foley et al. | Nov 2019 | B2 |
10478319 | Moskowitz et al. | Nov 2019 | B2 |
10492912 | Gregersen et al. | Dec 2019 | B2 |
10492922 | Mathieu et al. | Dec 2019 | B2 |
10492924 | Stein et al. | Dec 2019 | B2 |
10500064 | Robinson | Dec 2019 | B2 |
10512550 | Bechtel et al. | Dec 2019 | B2 |
10517645 | van der Pol | Dec 2019 | B2 |
10524924 | Davenport et al. | Jan 2020 | B2 |
10531903 | Daly et al. | Jan 2020 | B2 |
10537436 | Maguire et al. | Jan 2020 | B2 |
10537438 | Martynova et al. | Jan 2020 | B2 |
10555729 | Cole et al. | Feb 2020 | B1 |
10561411 | Cole et al. | Feb 2020 | B1 |
10575889 | Roybal | Mar 2020 | B2 |
10575960 | Duffield et al. | Mar 2020 | B2 |
10582959 | Langer et al. | Mar 2020 | B2 |
10583015 | Olmos et al. | Mar 2020 | B2 |
10603078 | Simpson et al. | Mar 2020 | B2 |
10610376 | Kuyler et al. | Apr 2020 | B2 |
10624757 | Bost et al. | Apr 2020 | B2 |
10624758 | Slivka et al. | Apr 2020 | B2 |
10624761 | Davenport et al. | Apr 2020 | B2 |
10639163 | Tyber et al. | May 2020 | B2 |
10639166 | Weiman et al. | May 2020 | B2 |
10653458 | Tanaka et al. | May 2020 | B2 |
10667925 | Emerick et al. | Jun 2020 | B2 |
10667927 | Lamborne et al. | Jun 2020 | B2 |
10675157 | Zakelj et al. | Jun 2020 | B2 |
10682241 | Glerum et al. | Jun 2020 | B2 |
10687963 | Jimenez et al. | Jun 2020 | B2 |
10702393 | Davenport et al. | Jul 2020 | B2 |
10709569 | McLaughlin et al. | Jul 2020 | B2 |
10709571 | Iott et al. | Jul 2020 | B2 |
10709572 | Daffinson et al. | Jul 2020 | B2 |
10709575 | Robinson | Jul 2020 | B2 |
10722377 | Glerum et al. | Jul 2020 | B2 |
10722379 | McLaughlin et al. | Jul 2020 | B2 |
10729561 | Glerum | Aug 2020 | B2 |
10743858 | Cole et al. | Aug 2020 | B1 |
10744002 | Glerum et al. | Aug 2020 | B2 |
10758366 | Daffinson et al. | Sep 2020 | B2 |
10758367 | Weiman et al. | Sep 2020 | B2 |
10758369 | Rogers et al. | Sep 2020 | B2 |
10765528 | Weiman et al. | Sep 2020 | B2 |
10772737 | Gray et al. | Sep 2020 | B2 |
10779955 | Kuyler et al. | Sep 2020 | B2 |
10779957 | Weiman et al. | Sep 2020 | B2 |
10786364 | Davenport et al. | Sep 2020 | B2 |
10786369 | Carnes et al. | Sep 2020 | B2 |
10799368 | Glerum et al. | Oct 2020 | B2 |
10835387 | Weiman | Nov 2020 | B2 |
10842640 | Weiman et al. | Nov 2020 | B2 |
10842644 | Weiman et al. | Nov 2020 | B2 |
10856997 | Cowan et al. | Dec 2020 | B2 |
10869769 | Eisen et al. | Dec 2020 | B2 |
10874447 | Tanaka et al. | Dec 2020 | B2 |
10874522 | Weiman | Dec 2020 | B2 |
10874523 | Weiman et al. | Dec 2020 | B2 |
10874524 | Bjork | Dec 2020 | B2 |
10881524 | Eisen et al. | Jan 2021 | B2 |
10881531 | Berry | Jan 2021 | B2 |
10888431 | Robinson | Jan 2021 | B1 |
10898344 | Alheidt et al. | Jan 2021 | B2 |
10898346 | Suddaby | Jan 2021 | B1 |
10925656 | Cole et al. | Feb 2021 | B2 |
10925750 | Zappacosta et al. | Feb 2021 | B2 |
10925752 | Weiman | Feb 2021 | B2 |
10932920 | Dewey et al. | Mar 2021 | B2 |
10940014 | Greenhalgh | Mar 2021 | B2 |
10945858 | Bechtel et al. | Mar 2021 | B2 |
10952866 | Warren et al. | Mar 2021 | B2 |
10959855 | Miller et al. | Mar 2021 | B2 |
10959856 | Seifert et al. | Mar 2021 | B2 |
10973649 | Weiman et al. | Apr 2021 | B2 |
10973650 | Stein | Apr 2021 | B2 |
10980642 | Glerum et al. | Apr 2021 | B2 |
10980644 | Purcell et al. | Apr 2021 | B2 |
10993814 | Wolters | May 2021 | B2 |
11007067 | Masson et al. | May 2021 | B2 |
11013617 | Weiman et al. | May 2021 | B2 |
11020238 | Nichols et al. | Jun 2021 | B2 |
11020239 | Miller et al. | Jun 2021 | B2 |
11026804 | Jimenez et al. | Jun 2021 | B2 |
11026812 | Daffinson et al. | Jun 2021 | B2 |
11033401 | Shoshtaev | Jun 2021 | B2 |
11033402 | Melkent et al. | Jun 2021 | B2 |
11033404 | Faulhaber | Jun 2021 | B2 |
11039935 | McAfee | Jun 2021 | B2 |
11045326 | Seifert et al. | Jun 2021 | B2 |
11045327 | Nichols et al. | Jun 2021 | B2 |
11051949 | Walker et al. | Jul 2021 | B2 |
11051951 | Robinson et al. | Jul 2021 | B2 |
11058469 | Mahajan et al. | Jul 2021 | B2 |
11065127 | Lentner et al. | Jul 2021 | B1 |
11065129 | Sandul | Jul 2021 | B2 |
11065130 | Branch et al. | Jul 2021 | B2 |
11076966 | Faulhaber | Aug 2021 | B2 |
11083584 | Lauf et al. | Aug 2021 | B2 |
11083595 | Robinson | Aug 2021 | B2 |
11090167 | Emerick et al. | Aug 2021 | B2 |
11096795 | Padovani et al. | Aug 2021 | B2 |
11096797 | Moskowitz et al. | Aug 2021 | B2 |
11103366 | Glerum et al. | Aug 2021 | B2 |
RE48719 | Suddaby et al. | Sep 2021 | E |
11109980 | Seifert et al. | Sep 2021 | B2 |
11116644 | Marrocco et al. | Sep 2021 | B2 |
11123198 | Black et al. | Sep 2021 | B2 |
11123200 | Faulhaber | Sep 2021 | B2 |
11129731 | Miller et al. | Sep 2021 | B2 |
11135071 | Dewey et al. | Oct 2021 | B2 |
11147680 | Tyber et al. | Oct 2021 | B2 |
11154404 | Freedman et al. | Oct 2021 | B2 |
11160666 | Burkhardt et al. | Nov 2021 | B2 |
11160669 | Rogers et al. | Nov 2021 | B2 |
11166826 | Huang | Nov 2021 | B2 |
11173044 | Jones et al. | Nov 2021 | B1 |
11179234 | Dacosta et al. | Nov 2021 | B2 |
11285014 | Josse et al. | Mar 2022 | B1 |
11376134 | Dewey et al. | Jul 2022 | B1 |
11617658 | Josse et al. | Apr 2023 | B2 |
11723780 | Seifert et al. | Aug 2023 | B2 |
20020045943 | Uk | Apr 2002 | A1 |
20020045945 | Liu et al. | Apr 2002 | A1 |
20020055741 | Schlapfer et al. | May 2002 | A1 |
20020116066 | Chauvin et al. | Aug 2002 | A1 |
20020128713 | Ferree | Sep 2002 | A1 |
20020151976 | Foley et al. | Oct 2002 | A1 |
20020183762 | Anderson et al. | Dec 2002 | A1 |
20030050701 | Michelson | Mar 2003 | A1 |
20030130739 | Gerbec et al. | Jul 2003 | A1 |
20030163132 | Chin | Aug 2003 | A1 |
20040102778 | Huebner et al. | May 2004 | A1 |
20040172134 | Berry | Sep 2004 | A1 |
20040186570 | Rapp | Sep 2004 | A1 |
20040193158 | Lim et al. | Sep 2004 | A1 |
20040204713 | Abdou | Oct 2004 | A1 |
20040249461 | Ferree | Dec 2004 | A1 |
20040254643 | Jackson | Dec 2004 | A1 |
20040254644 | Taylor | Dec 2004 | A1 |
20050015149 | Michelson | Jan 2005 | A1 |
20050033429 | Kuo | Feb 2005 | A1 |
20050033439 | Gordon et al. | Feb 2005 | A1 |
20050147478 | Greenberg | Jul 2005 | A1 |
20050154459 | Wolek et al. | Jul 2005 | A1 |
20050209698 | Gordon et al. | Sep 2005 | A1 |
20050228398 | Rathbun et al. | Oct 2005 | A1 |
20060122701 | Kiester | Jun 2006 | A1 |
20060129244 | Ensign | Jun 2006 | A1 |
20060260446 | Chang | Nov 2006 | A1 |
20060276901 | Zipnick et al. | Dec 2006 | A1 |
20070173840 | Huebner | Jul 2007 | A1 |
20070218750 | Corrao et al. | Sep 2007 | A1 |
20070233150 | Blain et al. | Oct 2007 | A1 |
20070270859 | Companioni et al. | Nov 2007 | A1 |
20080058804 | Lechot et al. | Mar 2008 | A1 |
20080132959 | Mikkonen et al. | Jun 2008 | A1 |
20080140207 | Olmos et al. | Jun 2008 | A1 |
20090024158 | Viker | Jan 2009 | A1 |
20090093830 | Miller | Apr 2009 | A1 |
20090105834 | Hovda et al. | Apr 2009 | A1 |
20090292361 | Lopez | Nov 2009 | A1 |
20100076440 | Pamichev et al. | Mar 2010 | A1 |
20100082109 | Greenhalgh et al. | Apr 2010 | A1 |
20100152853 | Kirschman | Jun 2010 | A1 |
20100191336 | Greenhalgh | Jul 2010 | A1 |
20100211176 | Greenhalgh | Aug 2010 | A1 |
20100286777 | Errico et al. | Nov 2010 | A1 |
20110118843 | Mathieu et al. | May 2011 | A1 |
20110130838 | Morgenstern Lopez | Jun 2011 | A1 |
20110153020 | Abdelgany et al. | Jun 2011 | A1 |
20110218572 | Lechmann et al. | Sep 2011 | A1 |
20110301577 | Simmen et al. | Dec 2011 | A1 |
20120004732 | Goel et al. | Jan 2012 | A1 |
20120095515 | Hamilton | Apr 2012 | A1 |
20120101581 | Mathieu et al. | Apr 2012 | A1 |
20120109142 | Dayan | May 2012 | A1 |
20120109309 | Mathieu et al. | May 2012 | A1 |
20120109310 | Mathieu et al. | May 2012 | A1 |
20120109312 | Mathieu et al. | May 2012 | A1 |
20120109313 | Mathieu et al. | May 2012 | A1 |
20120123546 | Medina | May 2012 | A1 |
20120143195 | Sander | Jun 2012 | A1 |
20120150237 | Combrowski | Jun 2012 | A1 |
20120197401 | Duncan et al. | Aug 2012 | A1 |
20120209385 | Aferzon | Aug 2012 | A1 |
20120215313 | Saidha et al. | Aug 2012 | A1 |
20120215316 | Mohr et al. | Aug 2012 | A1 |
20130158664 | Palmatier et al. | Jun 2013 | A1 |
20130184823 | Malberg | Jul 2013 | A1 |
20130190876 | Drochner et al. | Jul 2013 | A1 |
20130211526 | Alheidt et al. | Aug 2013 | A1 |
20130226191 | Thoren et al. | Aug 2013 | A1 |
20130231747 | Olmos et al. | Sep 2013 | A1 |
20130304136 | Gourlaouen-Preissler et al. | Nov 2013 | A1 |
20130317312 | Eastlack et al. | Nov 2013 | A1 |
20140018816 | Fenn et al. | Jan 2014 | A1 |
20140107790 | Combrowski | Apr 2014 | A1 |
20140114321 | Davenport et al. | Apr 2014 | A1 |
20140114420 | Robinson | Apr 2014 | A1 |
20140148904 | Robinson | May 2014 | A1 |
20140163682 | Iott et al. | Jun 2014 | A1 |
20140180419 | Dmuschewsky | Jun 2014 | A1 |
20140194992 | Medina | Jul 2014 | A1 |
20140249631 | Weiman | Sep 2014 | A1 |
20140277471 | Gray et al. | Sep 2014 | A1 |
20140277473 | Perrow | Sep 2014 | A1 |
20140277487 | Davenport et al. | Sep 2014 | A1 |
20140277500 | Logan et al. | Sep 2014 | A1 |
20140303674 | Sasing | Oct 2014 | A1 |
20140364855 | Stoll et al. | Dec 2014 | A1 |
20150223945 | Weiman et al. | Aug 2015 | A1 |
20150230931 | Greenhalgh | Aug 2015 | A1 |
20150238236 | Sasing | Aug 2015 | A1 |
20150354635 | McClymont et al. | Dec 2015 | A1 |
20150374507 | Wolters et al. | Dec 2015 | A1 |
20160008924 | Canourgues et al. | Jan 2016 | A1 |
20160022434 | Robinson | Jan 2016 | A1 |
20160051373 | Faulhaber | Feb 2016 | A1 |
20160058571 | McLaughlin et al. | Mar 2016 | A1 |
20160081681 | Waugh et al. | Mar 2016 | A1 |
20160089247 | Nichols et al. | Mar 2016 | A1 |
20160095710 | Juszczyk et al. | Apr 2016 | A1 |
20160095718 | Burkhardt et al. | Apr 2016 | A1 |
20160199073 | Nino et al. | Jul 2016 | A1 |
20160242930 | Duffield et al. | Aug 2016 | A1 |
20160256291 | Miller | Sep 2016 | A1 |
20160278830 | Arrington | Sep 2016 | A1 |
20160296340 | Gordon et al. | Oct 2016 | A1 |
20160310291 | Greenhalgh | Oct 2016 | A1 |
20160345952 | Kucharzyk et al. | Dec 2016 | A1 |
20160367377 | Faulhaber | Dec 2016 | A1 |
20170010025 | Mayershofer | Jan 2017 | A1 |
20170029635 | Doll et al. | Feb 2017 | A1 |
20170035406 | Abidin et al. | Feb 2017 | A1 |
20170049651 | Lim et al. | Feb 2017 | A1 |
20170049653 | Lim et al. | Feb 2017 | A1 |
20170095345 | Davenport et al. | Apr 2017 | A1 |
20170100255 | Hleihil et al. | Apr 2017 | A1 |
20170100257 | Weiman et al. | Apr 2017 | A1 |
20170105844 | Kuyler et al. | Apr 2017 | A1 |
20170112630 | Kuyler et al. | Apr 2017 | A1 |
20170151065 | Warren et al. | Jun 2017 | A1 |
20170156882 | Rathbun et al. | Jun 2017 | A1 |
20170156884 | Rathbun et al. | Jun 2017 | A1 |
20170189204 | Riemhofer et al. | Jul 2017 | A1 |
20170202678 | Duffield et al. | Jul 2017 | A1 |
20170215856 | Martinelli et al. | Aug 2017 | A1 |
20170224502 | Wolters et al. | Aug 2017 | A1 |
20170224504 | Butler et al. | Aug 2017 | A1 |
20170231675 | Combrowski | Aug 2017 | A1 |
20170246006 | Carnes et al. | Aug 2017 | A1 |
20170290677 | Olmos et al. | Oct 2017 | A1 |
20170296352 | Richerme et al. | Oct 2017 | A1 |
20170367842 | Predick | Dec 2017 | A1 |
20170367843 | Eisen et al. | Dec 2017 | A1 |
20170367844 | Eisen et al. | Dec 2017 | A1 |
20170367845 | Eisen et al. | Dec 2017 | A1 |
20180000606 | Hessler et al. | Jan 2018 | A1 |
20180030362 | Kosler et al. | Feb 2018 | A1 |
20180031810 | Hsu et al. | Feb 2018 | A1 |
20180036136 | Duffield et al. | Feb 2018 | A1 |
20180036138 | Robinson | Feb 2018 | A1 |
20180104066 | Bae et al. | Apr 2018 | A1 |
20180116891 | Beale et al. | May 2018 | A1 |
20180193160 | Hsu et al. | Jul 2018 | A1 |
20180193164 | Shoshtaev | Jul 2018 | A1 |
20180206999 | Suddaby | Jul 2018 | A1 |
20180256356 | Robinson et al. | Sep 2018 | A1 |
20180256359 | Greenhalgh | Sep 2018 | A1 |
20180256360 | Cain | Sep 2018 | A1 |
20180256362 | Slivka et al. | Sep 2018 | A1 |
20180263784 | Bechtel et al. | Sep 2018 | A1 |
20180271513 | Perrow et al. | Sep 2018 | A1 |
20180280142 | Schultz et al. | Oct 2018 | A1 |
20180303473 | Spann et al. | Oct 2018 | A1 |
20180303621 | Brotman et al. | Oct 2018 | A1 |
20180303625 | Alheidt et al. | Oct 2018 | A1 |
20180311048 | Glerum et al. | Nov 2018 | A1 |
20180318101 | Engstrom | Nov 2018 | A1 |
20180318102 | Seifert et al. | Nov 2018 | A1 |
20180325574 | Bjork et al. | Nov 2018 | A1 |
20180338838 | Cryder et al. | Nov 2018 | A1 |
20180338841 | Miller et al. | Nov 2018 | A1 |
20180344307 | Hynes et al. | Dec 2018 | A1 |
20180360616 | Luu | Dec 2018 | A1 |
20190000640 | Weiman | Jan 2019 | A1 |
20190000702 | Lim et al. | Jan 2019 | A1 |
20190000707 | Lim et al. | Jan 2019 | A1 |
20190020121 | Paulotto et al. | Jan 2019 | A1 |
20190021716 | Waugh et al. | Jan 2019 | A1 |
20190021873 | Dmuschewsky | Jan 2019 | A1 |
20190046329 | Padovani et al. | Feb 2019 | A1 |
20190046381 | Lim et al. | Feb 2019 | A1 |
20190046383 | Lim et al. | Feb 2019 | A1 |
20190060083 | Weiman et al. | Feb 2019 | A1 |
20190082949 | Weiman | Mar 2019 | A1 |
20190083081 | Ortiz et al. | Mar 2019 | A1 |
20190091033 | Dewey et al. | Mar 2019 | A1 |
20190105175 | Zappacosta et al. | Apr 2019 | A1 |
20190125328 | Blain | May 2019 | A1 |
20190133434 | Lee et al. | May 2019 | A1 |
20190133645 | Gordon et al. | May 2019 | A1 |
20190133779 | McLaughlin et al. | May 2019 | A1 |
20190133780 | Matthews et al. | May 2019 | A1 |
20190133782 | McLaughlin | May 2019 | A1 |
20190133784 | Gunn et al. | May 2019 | A1 |
20190133788 | Weiman et al. | May 2019 | A1 |
20190142480 | Woolley et al. | May 2019 | A1 |
20190151115 | Nichols et al. | May 2019 | A1 |
20190183656 | Stein | Jun 2019 | A1 |
20190201209 | Branch et al. | Jul 2019 | A1 |
20190201210 | Besaw et al. | Jul 2019 | A1 |
20190209155 | Mast et al. | Jul 2019 | A1 |
20190216453 | Predick et al. | Jul 2019 | A1 |
20190231552 | Sandul | Aug 2019 | A1 |
20190240039 | Walker et al. | Aug 2019 | A1 |
20190240043 | Greenhalgh | Aug 2019 | A1 |
20190247098 | Brumfield et al. | Aug 2019 | A1 |
20190254650 | Martinelli et al. | Aug 2019 | A1 |
20190254838 | Miller et al. | Aug 2019 | A1 |
20190254839 | Nichols et al. | Aug 2019 | A1 |
20190262009 | Cheng | Aug 2019 | A1 |
20190262139 | Wolters | Aug 2019 | A1 |
20190269521 | Shoshtaev | Sep 2019 | A1 |
20190274670 | O'Connell et al. | Sep 2019 | A1 |
20190274671 | Lauf et al. | Sep 2019 | A1 |
20190274836 | Eisen et al. | Sep 2019 | A1 |
20190282373 | Alheidt | Sep 2019 | A1 |
20190290446 | Masson et al. | Sep 2019 | A1 |
20190290447 | Stein | Sep 2019 | A1 |
20190298416 | Rezach | Oct 2019 | A1 |
20190298524 | Lauf et al. | Oct 2019 | A1 |
20190298540 | Aghayev et al. | Oct 2019 | A1 |
20190321022 | Karpowicz et al. | Oct 2019 | A1 |
20190321190 | Wagner et al. | Oct 2019 | A1 |
20190328539 | Suh et al. | Oct 2019 | A1 |
20190328540 | Seifert et al. | Oct 2019 | A1 |
20190329388 | Erickson et al. | Oct 2019 | A1 |
20190336301 | Engstrom | Nov 2019 | A1 |
20190336304 | Burkhardt et al. | Nov 2019 | A1 |
20190350573 | Vogel et al. | Nov 2019 | A1 |
20190358049 | Faulhaber | Nov 2019 | A1 |
20190358050 | Fessler | Nov 2019 | A1 |
20190358051 | Flower et al. | Nov 2019 | A1 |
20190380840 | Tyber et al. | Dec 2019 | A1 |
20190388232 | Purcell et al. | Dec 2019 | A1 |
20200008951 | McClintock et al. | Jan 2020 | A1 |
20200030114 | Cain | Jan 2020 | A1 |
20200030116 | Jimenez et al. | Jan 2020 | A1 |
20200038200 | Foley et al. | Feb 2020 | A1 |
20200054461 | Marrocco et al. | Feb 2020 | A1 |
20200060844 | Mathieu et al. | Feb 2020 | A1 |
20200069316 | DeSoutter et al. | Mar 2020 | A1 |
20200078190 | Rogers et al. | Mar 2020 | A1 |
20200093526 | Daly et al. | Mar 2020 | A1 |
20200093607 | Davenport et al. | Mar 2020 | A1 |
20200093609 | Shoshtaev | Mar 2020 | A1 |
20200100904 | Stein et al. | Apr 2020 | A1 |
20200129306 | Miller et al. | Apr 2020 | A1 |
20200129307 | Hunziker et al. | Apr 2020 | A1 |
20200138591 | Moskowitz et al. | May 2020 | A1 |
20200138593 | Martynova et al. | May 2020 | A1 |
20200146840 | Black et al. | May 2020 | A1 |
20200179120 | Bielenstein et al. | Jun 2020 | A1 |
20200205993 | Davenport et al. | Jul 2020 | A1 |
20200214754 | Bowen et al. | Jul 2020 | A1 |
20200222202 | Kuyler et al. | Jul 2020 | A1 |
20200229944 | Suh et al. | Jul 2020 | A1 |
20200246159 | Suh et al. | Aug 2020 | A1 |
20200246162 | Schultz et al. | Aug 2020 | A1 |
20200261242 | Bost et al. | Aug 2020 | A1 |
20200268524 | Glerum et al. | Aug 2020 | A1 |
20200276028 | Blain et al. | Sep 2020 | A1 |
20200281741 | Grotz | Sep 2020 | A1 |
20200289287 | Emerick et al. | Sep 2020 | A1 |
20200297507 | Iott et al. | Sep 2020 | A1 |
20200330239 | Davenport et al. | Oct 2020 | A1 |
20200330245 | Glerum | Oct 2020 | A1 |
20200345511 | Daffinson et al. | Nov 2020 | A1 |
20200352731 | Berry | Nov 2020 | A1 |
20200352738 | Berry | Nov 2020 | A1 |
20200360153 | Weiman et al. | Nov 2020 | A1 |
20200375753 | McLaughlin et al. | Dec 2020 | A1 |
20200375755 | Cain | Dec 2020 | A1 |
20200383797 | Predick et al. | Dec 2020 | A1 |
20200383799 | Cain | Dec 2020 | A1 |
20200390565 | Jimenez et al. | Dec 2020 | A1 |
20200397593 | Davenport et al. | Dec 2020 | A1 |
20200405497 | Olmos et al. | Dec 2020 | A1 |
20200405498 | Gray et al. | Dec 2020 | A1 |
20200405499 | Gerbec et al. | Dec 2020 | A1 |
20200405500 | Cain | Dec 2020 | A1 |
20210007860 | Glerum et al. | Jan 2021 | A1 |
20210015626 | Suddaby | Jan 2021 | A1 |
20210030555 | Weiman et al. | Feb 2021 | A1 |
20210030561 | Gleason | Feb 2021 | A1 |
20210045891 | Rogers et al. | Feb 2021 | A1 |
20210045892 | Rogers et al. | Feb 2021 | A1 |
20210052395 | Iott et al. | Feb 2021 | A1 |
20210068959 | McLuen et al. | Mar 2021 | A1 |
20210068974 | Cowan et al. | Mar 2021 | A1 |
20210068982 | Carnes et al. | Mar 2021 | A1 |
20210077271 | Sharabani | Mar 2021 | A1 |
20210077272 | Eisen et al. | Mar 2021 | A1 |
20210085479 | Weiman et al. | Mar 2021 | A1 |
20210093462 | Lucasiewicz et al. | Apr 2021 | A1 |
20210106434 | Alheidt et al. | Apr 2021 | A1 |
20210113349 | Weiman et al. | Apr 2021 | A1 |
20210121299 | Hyder | Apr 2021 | A1 |
20210121300 | Weiman et al. | Apr 2021 | A1 |
20210137697 | Weiman | May 2021 | A1 |
20210137699 | Jang et al. | May 2021 | A1 |
20210137701 | Miller et al. | May 2021 | A1 |
20210154811 | Spreiter et al. | May 2021 | A1 |
20210161678 | Dewey et al. | Jun 2021 | A1 |
20210177618 | Branch et al. | Jun 2021 | A1 |
20210186706 | Spitler et al. | Jun 2021 | A1 |
20210186709 | Weiman et al. | Jun 2021 | A1 |
20210196470 | Shoshtaev | Jul 2021 | A1 |
20210205092 | Glerum et al. | Jul 2021 | A1 |
20210205094 | Weiman et al. | Jul 2021 | A1 |
20210220145 | Stein | Jul 2021 | A1 |
20210220147 | Berry | Jul 2021 | A1 |
20210236298 | Weiman et al. | Aug 2021 | A1 |
20210251770 | Purcell et al. | Aug 2021 | A1 |
20210251776 | Daffinson et al. | Aug 2021 | A1 |
20210259848 | Kang et al. | Aug 2021 | A1 |
20210259849 | Robinson et al. | Aug 2021 | A1 |
20210259850 | Eisen et al. | Aug 2021 | A1 |
20210267767 | Stein | Sep 2021 | A1 |
20210275317 | Spetzger | Sep 2021 | A1 |
20210275318 | Reimels | Sep 2021 | A1 |
20210275319 | Reimels | Sep 2021 | A1 |
20210275321 | Seifert et al. | Sep 2021 | A1 |
20210282938 | Nichols et al. | Sep 2021 | A1 |
20210298915 | Faulhaber | Sep 2021 | A1 |
20210298916 | Melkent et al. | Sep 2021 | A1 |
20210307920 | Walker et al. | Oct 2021 | A1 |
20210315705 | Altarac et al. | Oct 2021 | A1 |
20210322179 | Miller et al. | Oct 2021 | A1 |
20210322181 | Predick | Oct 2021 | A1 |
20210322182 | Faulhaber | Oct 2021 | A1 |
20210330472 | Shoshtaev | Oct 2021 | A1 |
20210346174 | Flint et al. | Nov 2021 | A1 |
20220015924 | Freedman et al. | Jan 2022 | A1 |
20220047312 | Seykora et al. | Feb 2022 | A1 |
20220133336 | Tsai et al. | May 2022 | A1 |
20220133497 | Dewey et al. | May 2022 | A1 |
20220133498 | Josse et al. | May 2022 | A1 |
20220133499 | Josse et al. | May 2022 | A1 |
20220218325 | Josse | Jul 2022 | A1 |
20220387184 | Josse et al. | Dec 2022 | A1 |
20230027836 | Predick et al. | Jan 2023 | A1 |
Number | Date | Country |
---|---|---|
107 137 166 | Sep 2017 | CN |
44 16 605 | Jun 1995 | DE |
0 767 636 | Apr 1997 | EP |
0 880 950 | Dec 1998 | EP |
0 857 042 | Nov 2001 | EP |
1 442 732 | Aug 2004 | EP |
1 124 512 | Sep 2004 | EP |
1 107 711 | Oct 2004 | EP |
1 506 753 | Feb 2005 | EP |
1 459 711 | Jul 2007 | EP |
2954860 | Dec 2015 | EP |
3031424 | Jun 2016 | EP |
3 069 694 | Sep 2016 | EP |
3213720 | Sep 2017 | EP |
2781998 | Feb 2000 | FR |
3082115 | Dec 2019 | FR |
2 377 387 | Jan 2003 | GB |
102192022 | Dec 2020 | KR |
9214423 | Sep 1992 | WO |
97 00054 | Jan 1997 | WO |
99 26562 | Jun 1999 | WO |
9966867 | Dec 1999 | WO |
0012033 | Mar 2000 | WO |
0025706 | May 2000 | WO |
00 49977 | Aug 2000 | WO |
0219952 | Mar 2002 | WO |
03105673 | Dec 2003 | WO |
2006116850 | Nov 2006 | WO |
2012139022 | Oct 2012 | WO |
2014133755 | Sep 2014 | WO |
2015063721 | May 2015 | WO |
2015198335 | Dec 2015 | WO |
2016057940 | Apr 2016 | WO |
2017168208 | Oct 2017 | WO |
2018049227 | Mar 2018 | WO |
2021055323 | Mar 2021 | WO |
Entry |
---|
International Search Report and Written Opinion in Application No. PCT/IB2023/057720 dated Nov. 8, 2023. |
International Search Report, and Written Opinion for Application. No. PCT/US2019/019067, dated Jun. 3, 2019. |
International Search Report, and Written Opinion for Application. No. PCT/US2019/019060, dated Jun. 5, 2019. |
International Search Report and Written Opinion, PCT/IB2020/000932, Dated Jul. 29, 2021. |
International Search Report and Written Opinion, PCT/IB2020/000942, Dated Aug. 10, 2021. |
European Search Report, EP19756905, Dated Oct. 18, 2021. |
International Search Report and Written Opinion, PCT/US2022/016809, dated Jul. 27, 2022. |
International Search Report and Written Opinion in Application No. PCT/US2022/027695 dated Jul. 27, 2022. |
International Search Report and Written Opinion in Application No. PCT/US2022/027200 dated Aug. 19, 2022. |
International Search Report and Written Opinion in Application No. PCT/US2022/030094 dated Sep. 16, 2022. |
International Search Report and Written Opinion in Application No. PCT/US2022/016831 dated Sep. 29, 2022. |
Chinese Office Action in Application No. 201980010758.4 dated Jun. 16, 2023. |
Chinese Office Action in Application No. 201980010758.4 dated Sep. 16, 2023. |
International Search Report and Written Opinion in Application No. PCT/IB2023/058417 dated Dec. 7, 2023. |
Number | Date | Country | |
---|---|---|---|
20230372120 A1 | Nov 2023 | US |
Number | Date | Country | |
---|---|---|---|
62633952 | Feb 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17246959 | May 2021 | US |
Child | 18366101 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16282654 | Feb 2019 | US |
Child | 17246959 | US |